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ABSTRACT
Type 2 isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IDI-2) 
catalyzes the reversible conversion of isopentenyl diphosphate (IPP) to dimethylallyl 
diphosphate (DMAPP). The enzyme requires a divalent cation (Mg2+) and a reduced 
flavin mononucleotide (FMNred) cofactor to be catalytically active. To probe the role of 
FMNred, substrate analogues were incubated with enzyme-bound FMNred and analyzed 
under various conditions by UV-vis absorption and fluorescence spectroscopy. The 
spectral characteristics indicated a covalent bond was formed between the analogues and 
flavin at either the C4a- or N5-position (dependent on the substrate analogues). Similar 
methodology was applied to study a flavin adduct that formed when IDI-2 was incubated 
with IPP or DMAPP. Furthermore, mass spectrometry demonstrated that this adduct was 
the result of a loss of inorganic diphosphate and yielded a single isoprene unit addition to 
flavin. Bond formation observed with many analogues and the natural substrates supports 
a role where flavin is involved with catalysis directly as a proton donor/acceptor and/or as 
a stabilizer of an intermediate.
Additionally, the kinetic mechanism was established for the apo form of 
Streptococcus pneumoniae IDI-2, a potential antibacterial drug target. Bisubstrate studies 
(where IPP and FMN were varied) and competitive inhibition experiments (with a 
competitive inhibitor of both substrates) were employed to determine an ordered 
sequential mechanism, where FMN binds first. The kinetic data appeared sigmoidal and
could only be fit when Hill coefficients where included in the mathematical models, 
particularly for FMN. The Hill coefficients were thoroughly evaluated statistically and 
their inclusion was determined to be significant, thus a possible cooperative or allosteric 
effect occurs upon the binding of FMN. These experiments suggest that allosteric 
inhibitors could be investigated to inactivate the S. pneumoniae IDI-2 enzyme.
In a different application of statistics, transient kinetic isotope effect studies were 
evaluated using the bootstrap statistical technique. While statistically significant isotope 
effects were determined, the values were 100 % larger than expected. Thus, the technique 
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CHAPTER 1
INTRODUCTION
Biological Diversity of Isoprenoid Compounds
Isoprenoids are biological compounds derived from the five-carbon precursors 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) (Figure 1.1). 
Biological diversity is introduced through chain elongation, the process of joining 
DMAPP to IPP with subsequent additions o f IPP to the resulting products. Chain 
elongation forms the monoterpenes (ten-carbon structures), sesquiterpenes (fifteen- 
carbon structures), diterpenes (twenty-carbon structures), and so on up to natural rubber 
(30,000+ carbon structure). According to current estimates, there are over 60,000 
isoprenoid compounds,1 including the hemiterpenes (five-carbon units). The derivation of 
the term isoprene is unknown,2 but was first introduced in 1860 to a liquid distilled from 
caoutchouc (rubber) with a boiling point ~ 37 °C and a formula C5H8.3 The use of the 
word terpene to describe compounds with the empirical formula C10H 16 is derived from 





Figure 1.1. Building blocks of isoprenoid compounds.
2the etymology of the word Terpene in the German chemical literature and traced its use
chemical literature appears to be a direct use of the German word, without translation to
terpenes are now known to be ubiquitous and essential throughout nature.
The isoprenoid compounds serve a wide variety of essential biological functions 
and serve as secondary (nonessential, but important for species survival) metabolites. 
Here are a brief summary of different subsets of isoprenoid compounds and a mention of 
their biological function. Terpenoids are used by plants as an attractant or deterrent for 
pollinators, defense against herbivores, and an attractant to beneficial predators.7,8 
Isoprene (a hemiterpene) (Figure 1.2) is emitted from plants during times of high 
temperature, serving to cool plant leaves.9 L-, or (-)-menthol (Figure 1.2), a monoterpene 
produced by peppermint and cornmint (Mentha piperita and arvensis species, 
respectively), has a yearly worldwide demand of 25 -  30,000 metric tons.10 Products that 
use menthol include toothpaste, candy, medical supplements, liquors, cigarettes, air 
fresheners and various cleaning products. In Homo sapiens, menthol activates the 
transient receptor potential (TRP) melastatin 8 receptor, an ion channel responsible for 
detection of cold environmental stimuli, which is the cause of the cooling sensation attri-
Figure 1.2. Structures of isoprene, (-)-menthol, (E)-p-caryophyllene and artemisinin.
to the early to mid-part of the nineteenth century.5 The first use of terpene in the English






European varieties and the wild ancestor of maize are capable of emitting (E)-P- 
caryophyllene (Figure 1.2) when the Western corn rootworm (WRC) invades and 
damages the plant.12 The sesquiterpene attracted entomopathogenic nematodes and 
parasitic wasps that are natural predators of WRC.13 Introduction of the (E)-P- 
caryophyllene gene into a North American variety, most of which do not produce the 
compound, successfully imparted the trait of attracting beneficial predators.14 Thus, (E)- 
P-caryophyllene may be a natural alternative to pesticides used to control WRC.
Another sesquiterpene, artemisinin (Figure 1.2) is an antimalarial compound 
derived from the herb Artemisia annua that was used in Chinese traditional medicine to 
cure fever and malaria.15 The isolated compound reduces the mortality rate of severe 
malaria by 35 % compared to quinine, but access to the compound is limited and the drug 
is cost prohibitive in economically poor areas.16
Two other economically important terpenes are geosmin (degraded sesquiterpene) 
and 2-methylisoborneol (MIB) (methylated monoterpene) (Figure 1.3) because they 
confer, respectively, an earthy and musty off-flavor to water, which requires expensive 
methods to eradicate.17 Geosmin and MIB are responsible for the earthy odor often 




Figure 1.3. Structures of geosmin, 2-methylisoborneol and gibberellin A3.
soil bacteria as well as a number of other bacteria.17,18 The compounds are also relevant 
agriculturally as geosmin is biosynthesized by the beet plant and contributes to their 
earthy flavor,19 while the notes of must in Brie cheese are associated with MIB.20
Some longer chain terpenes include the gibberellins (diterpenes) (Figure 1.3) that 
function to promote plant growth in a variety of ways that include shoot elongation, 
flower production, seed germination and decrease of seed production.21 The triterpene 
squalene is formed through a tail-to-tail condensation of two molecules of the 
sesquiterpene farnesyl diphosphate (FPP). Squalene (Figure 1.4) is then cyclized and 
rearranged in different ways to produce sterols such as cholesterol and campesterol 
(Figure 1.4), which serve to stabilize cell membranes in animals and plants, 
respectively.22 The carotenoids are tetraterpenes found in plants that act as pigments to 
aid in photosynthesis and as color attractants for birds and bees.23 In human health, P- 




Figure 1.4. Structures of squalene, p-carotene, cholesterol and campesterol.
which is necessary for proper functioning of the human eye light receptors.24 The 
polymeric nature of isoprenoid compounds extends to natural rubber, a product found in 
the latex from the tree, Hevea brasiliensis that has an average of 7000 isoprene units per 
molecule.25 Beyond the chain elongation and cyclization of polyisoprene units, the 
prenylation of different families of natural products as well as the functionalization of 
isoprenoids are ubiquitous in nature.
Iridoid and secoiridoid compounds are plant defense compounds composed of a 
cyclopentane (iridoid) or cleaved ring (secoiridoid) fused to a six-membered ring with an 
oxygen (monoterpene component) and a glucose substituent (Figure 1.5).26 The 
secoiridoid 3a(S)-strictosidine is the precursor to numerous monoterpene indole 
alkaloids, including quinine (Figure 1.5).22
Prenylated polyketides (or meroterpenoids) include hyperforin (Figure 1.5) from 
St. John's wort and the hop bitter acids. Hyperforin is responsible for the well-known 
antidepressant characteristics of St. John’s wort, and has demonstrated antibacterial and 
anticancer properties.27 Humulone is the major component of the hop bitter a-acids (35 -  
70 %) and isconverted to isohumulone during the brewing process (Figure 1.5). 
Collectively, the hop bitter acids have anticancer, anti-inflammatory, bactericidal and 
antioxidant properties.28
The biodiversity of the isoprenoid family of compounds is extensive. 
Moenomycins are antibiotics with a pentasaccharide bound to an irregular isoprenoid 
chain through a phosphoglycerate-ether (Figure 1.5).29 Paclitaxel (Taxol) (Figure 1.6) is a 
diterpene with amino acids side chains discovered in the bark of the Pacific yew that has 
demonstrated anticancer activity.22 Saponins are polycyclic (four or five) triterpenoids
5









Figure 1.5. Structures of loganin, secologanin, 3a(S)-strictosidine, quinine, 
humulone, isohumulone, hyperforin and moenomycin A.
7Figure 1.6. Structures of taxol, glycyrrhizic acid, a dolichol and coenzyme Q10.
with one to three carbohydrate substituents that generally have a bitter taste. Glycyrrhizic 
acid (Figure 1.6), from licorice root, is a saponin that is sweet and has anti-inflammatory 
properties.22 Beyond small molecules, dolichols (Figure 1.6) serve as the lipid component 
of glycolipids of eukaryotic cells and have a saturated prenol attached to 8 to 20 cis- 
prenyl units terminating with 2 or 3 trans-prenyl units.30 Ubiquinones are polyprenylated 
benzoquinones, such as Coenzyme-Q10 (Figure 1.6), important compounds in the electron 
transfer reactions of mitochondrial respiratory chains.31 Unique to the Archaea kingdom 
of life, Archaeal cell membranes (Figure 1.7) are composed of two saturated diterpene 
chains independently attached to glycerol through an ether linkage.32 In addition to 
natural products, prenylation occurs with proteins and has been observed in RNA.
Proteins in the Ras superfamily are involved in cell growth and differentiation,
8-o p o 3h 1
Archaeol (Archeael Membrane Lipid)
NH O
N
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5-Carboxymethylaminomethyl-2-thiouridine
Figure 1.7. Structures of archaeol, a farnesylated peptide, 5-methylaminomethyl-2- 
thiouridine and 5-carboxymethylaminomethyl-2-thiouridine.
and are posttranslationally prenylated for membrane association. Farnesylation (or 
geranylgeranylation) occurs at a C-terminal cysteine that is a part of a CAAX motif of 
amino acids where A is an aliphatic residue and X is a variable group that is limited to C,
S, M, Q, or A for activity (Figure 1.7).33 The functionality of mutated Ras proteins has 
been associated to one-third of human cancers, with mutations in the K-Ras proteins 
being even more associated with colorectal and pancreatic cancers (50 and 90 %, 
respectively).34 Geranylated RNA in bacteria occurs at the sulfur atom of 5- 
methylaminomethyl- or 5-carboxymethylaminomethyl-2-thiouridine (Figure 1.7).35 The 
prenylation causes a decrease in codon bias for the glutamate UUC tRNA when GAA 
versus GAG codons are translated. The expansive use of isoprenoid compounds in nature 
is the biosynthetic result of two independent and unique pathways.
9The Pathways of Isoprenoid Biosynthesis
The biosynthesis of isoprenoids occurs through either the mevalonic acid (MVA) 
(Figure 1.8) or the methylerythritol 4-phosphate (MEP) (Figure 1.9) pathways. The MVA 
pathway was discovered in the 1950s by demonstration that 14C-labeled mevalonic acid 
led to the 14C-labeled isoprenoids squalene, P-carotene, rubber, and a-pinene.36 The first 
step of the MVA pathway is the condensation of two molecules of acetyl-CoA to form 
acetoacetyl-CoA. Acetoacetyl-CoA is then condensed with another acetyl-CoA molecule 
to form P-hydroxy-P-methylglutaryl-CoA (HMG-CoA). The reduction of HMG-CoA 
with NADPH results in mevalonic acid. Phosphorylation of mevalonate leads to 5- 
phosphomevalonate and the pathway then diverges for the Eukaryote and Archaea MVA 
pathways. Eukaryotes possess phosphomevalonate kinase, an enzyme that gives 
mevalonate 5-diphosphate. Diphosphomevalonate decarboxylase (or mevalonate-5- 
diphosphate decarboxylase) completes the isoprenoid pathway in eukaryotes to yield IPP. 
In Archaea, a hypothetical phosphomevalonate decarboxylase produces isopentenyl 
phosphate (IP) that is then phosphorylated by the well characterized isopentenyl 
phosphate kinase to yield IPP.37 Archaea lack a diphosphomevalonate decarboxylase 
homologue and the enzyme that carries out this hypothetical reaction is still unknown.38
The MEP pathway (Figure 1.9) was more recently discovered. Early evidence in 
the late 1980s included unexpected patterns in terpenes when bacteria were fed 
isotopically labeled acetate.39 In the early 1990s, [U-13C6]-glucose was fed to E. coli and 
labels were incorporated into ubiquinone-8 in a pattern that revealed pyruvate, not acetyl- 
CoA was the source an IPP two carbon unit.40 Specifically labeled glucose, acetate, 
pyruvate and erythrose were fed to bacteria and the source of each carbon in IPP was
10
O A A C T  ® OII AAU1 II II
C oA ^'- ------C o A ^ ^ ^
|  HMGS
O - OH O
CoaA ^ A 0 - 
|  HMGR
■4 OHO
|  MVK 
O OH O
H 0- - - 0- - _ X , A 0
PMD y \^PM K
O | 0  0  OH OII II II '  ^ ■
H 0 '^ 0 '^ VsX' ^  H 0 '5 "0 'J>'0 '  ^  ^  "OO- O- O-
\  /IPK x  '  MPD
O OII II
H O ^ O ^ O  





Figure 1.8. Mevalonic acid biosynthetic pathway of isoprenoid production with the 
enzymes responsible for each step. Enzyme abbreviations represent: AACT, 
Acetoacetyl-CoA thiolase; HMGS, 3-Hydroxy-3-methylglutaryl-CoA synthase; 
HMGR, 3-Hydroxy-3-methylglutaryl-CoA reductase; MVK, Mevalonate kinase; 
PMD, Phosphomevalonate decarboxylase (hypothetical); IPK, Isopentenyl 
phosphate kinase; PMK, Phosphomevalonate kinase; MPD, Mevalonate-5- 
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Figure 1.9. Methylerythritol phosphate biosynthetic pathway of isoprenoid 
production with the enzymes responsible for each step. Enzyme abbreviations 
represent: DXS, DXP synthase; DXR, DXP reductoisomerase; IspG, 2-C-methyl-D- 
erythritol-2,4-cyclodiphosphate reductase; IspH, 4-hydroxyl-3-methyl-butenyl-1- 
diphosphate reductase.
determined, which identified a source novel to that of the MVA pathway.41 Two 
isoprenoid precursors were identified when isotopically labeled glycerol and pyruvate 
were incorporated into E. coli isoprenoids.42 Sometimes called the nonmevalonate 
pathway, mevalonate-independent pathway or 1-deoxyxyluluose 5-phosphate (DXP) 
pathway, the first step of the MEP pathway is the condensation of pyruvate with 
glyceraldehyde-3-phosphate (G3P) to form DXP. In the next step, DXP undergoes an a- 
ketol rearrangement followed by reduction by NADPH to yield 2C-methyl-D-erythritol
4-phosphate, which is then condensed with cytidine diphosphate to give 4- 
diphosphocytidyl-2C-methyl-D-erythritol. Phosphorylation of the C2 hydroxyl group 
results in 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate that is then cyclized to 
2C-methyl-D-erythritol 2,4-cyclodiphosphate (MECP). The cyclized MECP is converted 
to (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate, which is then reduced to a mixture of 
IPP and DMAPP in a 5:1 ratio.43
Isopentenyl Diphosphate:Dimethylallyl Diphosphate Isomerase
In eukaryotes, prokaryotes, and Archaea that utilize the MVA pathway, 
isopentenyl diphosphate isomerase (IDI) is an essential enzyme that interconverts IPP to 
DMAPP (Figure 1.8). Organisms synthesizing IPP by the MEP pathway use IDI to 
balance cellular levels of IPP and DMAPP. The IDI enzyme is distributed in nature as 
two nonhomologous isofunctional (NIS)44 forms, termed type 1 (IDI-1) and type 2 (IDI- 
2). Eukaryotes utilize IDI-1 exclusively; type 2 orthologs have not been observed in any 
eukaryotic genome sequenced to date. The type 2 NIS form is found in Archaea and 
Bacteria, such as the Actinobacteria, Bacillales, Cyanobacteria, Lactobacillales, and 
Proteobacteria phyla.45 The majority (~ 72 %) of prokaryotic genomes that contain the
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MEP pathway possess no IDI genes. Of the remainder, 17 % have IDI-1, 10 % have IDI- 
2, and 1 % possesses both genes. IDI-2 is a potential antibacterial drug target, since 
humans utilize the type 1 enzyme while type 2 is used by some pathogenic bacteria.46
Analogous to the MVA and MEP pathway, IDI-1 was discovered well before IDI-
2. The early discovery of IDI-1 was not serendipitous but was directly related to the study 
of the MVA pathway. Isopentenyl diphosphate was discovered in 1958 while the 
pathway from mevalonate to squalene was studied.47 IDI-1 was first isolated from a yeast 
extract and established that the catalyzed reaction was reversible. This study also found 
the enzyme in rat liver, kidney and brain tissues.48
The type 1 enzyme requires Mg2+ to coordinate the diphosphate moiety of IPP 
and Zn2+ (or Mn2+) to help orient the active site amino acid side chains by coordination to 
three histidine and two glutamate residues (Figure 1.10).49,50 Crystal structures of E. coli
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Figure 1.10. Crystal structure of E. coli IDI-1 with NIPP in the active site (with 
NIPP structure to the right). The green and purple spheres represent Mg2+ and 
Mn2+, respectively. NIPP is cyan in color. PDB code 1NFS.
suggest that E116 is the proton donor, and C67 abstracts the proton to yield DMAPP. The 
structure in Figure 1.11 shows an epoxy analogue covalently attached to C67.51,52 
Catalysis proceeds through an antarafacial protonation/deprotonation mechanism with a 
carbocationic intermediate (Figure 1.12).53-55 The carbocation is stabilized by the 
glutamate that donated a proton and by cation-n stabilization of the indole ring in 
W161.51 An active site tyrosine (Y104) was implicated as the proton donor,51 but later 
found to play an important structural role rather than a catalytic one.56
IDI-2 was discovered in 2000. The enzyme requires a divalent cation (Mg2+) and 
reduced FMN cofactor for activity.57 In contrast to the majority of flavoenzymes, which 
are redox active, IDI-2 catalyzes an acid/base-like reaction. The native enzyme is a 
tetramer or octomer in solution and has been crystallized in each form. The monomeric 
unit has a triosephosphate isomerase (TIM) barrel structure (Figure 1.13 for the S.
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Figure 1.11. Crystal structure of E. coli IDI-1 with Epoxy-IPP in the active site (with 
Epoxy-IPP structure to the right). The green and purple spheres represent Mg2+ 
















Figure 1.12. Mechanism of IDI-1 with amino acid numbering based on the E. coli 
enzyme.
shibitae tetramer).58,59 The FMN cofactor is located in the P-sheets of the TIM barrel 
(Figure 1.14). The hydrocarbon moiety in IPP is in a plane parallel to and directly over 
the face of the isoalloxazine ring system (Figure 1.15 and Figure 1.16). The C2-C3-C4 
positions of IPP are 3.3 -  3.8 A from either N5 or C4a in FMN (Figure 1.17). Within the 
active site, the carbocation formed by protonation of IPP is stabilized within a box 
formed by FMN on the bottom. One pair of opposing walls of this box is H155 and W225 
near the pyrimidyl and benzyl rings of FMN, respectively. The other pair is H11 and 
S195 near the diphosphate and C4/C5 of the substrate, respectively (Figure 1.18). The
16
Figure 1.13. Tetrameric crystal structure of S. shibitae IDI-2 with IPP (cyan), FMN 
(yellow) and Mg2+ (green sphere). Structure from PDB file 3B05.
Figure 1.14. Monomer of the tetrameric crystal structure of S. shibitae IDI-2 with 
IPP (cyan), FMN (yellow) and Mg2+ (green sphere). Structure from PDB file 3B05.
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Figure 1.15. Close-up view of the positioning of FMN (yellow) and IPP (cyan) in the 
S. shibitae IDI-2 active site. The green sphere is Mg2+. Structure from PDB file 3B05.
Figure 1.16. Close-up view of the positioning of IPP (cyan) directly above FMN 
(yellow) in the S. shibitae IDI-2 active site. The green sphere is Mg2+. Structure from 
PDB file 3B05.
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Figure 1.17. Distances between IPP carbons (cyan) and FMN (yellow) in the S. 
shibitae IDI-2 active site. A, Flavin N5; B, Flavin C4a. Structure from PDB file 
3B05.
box is capped by Q160, which also stabilizes the carbocationic intermediate. Below IPP 
(relative to Figure 1.18) is a histidine residue and above is a serine or valine (for S. 
shibitae or T. thermophilus, respectively). N157 coordinates with H155, Q160 and Mg2+. 
In the mechanistic description that follows, these amino acids will not be further 
discussed as their purpose is to position the substrate and stabilize the carbocation 
intermediate produced during catalysis.
The isomerization catalyzed by IDI-2 is highly stereoselective. The pro-R 
hydrogen of IPP is removed during isomerization of IPP to DMAPP, and a proton is 
removed from the E-methyl group of DMAPP in the reverse reaction.60,61 Chiral methyl 
analysis found that with E- and Z- 4-T-IPP the allylic product E-methyl groups were (R) 




Figure 1.18. Positioning of IPP (cyan) within the active site of S. shibitae IDI-2 with 
FMN (yellow) and Mg2+ (green sphere). A and B are just opposing views of the same 
structure. Structure from PDB file 3B05.
R-[4-D,T]-DMAPP S-[4-D,T]-DMAPP
Figure 1.19. Chiral methyl analysis substrates and products.
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Two mechanisms with radical or carbocationic intermediates were initially 
proposed for IDI-2 (Figure 1.20). UV-vis spectra indicated that when reduced, FMN was 
converted to the fully reduced anionic state in the absence of substrate. When IPP was 
incubated with IDI-2 prior to photoreduction, FMN underwent a one-electron reduction 
to yield the neutral semiquinone state.63 The redox potentials for flavin bound to IDI-2 in 
the presence of IPP are different from those for free flavin. In Staphylococcus aureus 
IDI-2, the midpoint potential is -160 mV for the oxidized/semiquinone pair and -233 mV 
for the semiquinone/reduced pair.64 In contrast, the corresponding midpoint potentials for 
free flavin were -313 mV and -101 mV, respectively.65 The higher redox potentials 
indicated that IPP might contribute to stabilizing the semiquinone, possibly as a radical 
pair. EPR spectroscopy was used unsuccessfully to detect the semiquinone species.63,66 
Cyclopropyl and epoxy substrate analogues for IDI-2 (Figure 1.21) were unsuccessful in 
the detection of radical intermediates by "radical clock" mechanisms.67,68 The 
cyclopropylcarbinyl and oxiranylcarbinyl radicals rearrange to the homoallylic isomers at 
rates of ~1.8 x 107 and 3.2 x 1010 s-1, respectively.69,70 When IDI-2 was incubated with 
the cyclopropyl analogue, NMR spectroscopy detected isomerization to cyclopropyl 
DMAPP without any evidence of a rearranged product. With the epoxy analogue,
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3-Butyn-l-yl PP; 3,4-Butadien-l-yl PPj Vinyl thioether IPP
Figure 1.21. IPP analogues discussed in the text.
epoxide opening with formation of a flavin adduct was observed without rearrangement 
to the homoallylic product expected for a radical reaction.
Additional evidence against a radical intermediate was found when alkyne and
alkyne and allene derivatives were not alternative substrates and were not time- 
dependent, covalent inhibitors. The heats of reaction for formation of a carbocation by 
protonation of alkyne and allene derivatives was calculated to be -179 and -177 kcal/mol, 
respectively, while the corresponding values for formation of radicals by hydrogen atom 
additions were -37 and -36 kcal/mol, respectively. In comparison, the heats of 
protonation of 2-methyl-1-butene and 2-methyl-2-butene (-193 and -192 kcal/mol, 
respectively) are ~ 15 kcal/mol lower than for protonation of the related alkyne and allene 
derivatives. In contrast, heats of hydrogen atom addition to 2-methyl-1-butene and 2- 
methyl-2-butene (-34 and -33 kcal/mol, respectively), are nearly the same (~ 2 kcal/mol) 
as those for hydrogen atom addition. Thus, for an isomerization reaction proceeded by a 
radical mechanism, the alkyne/allene analogues would be good substrates or result in 
adduct formation to the flavin. The absence of turnover for both IDI-1 (as mentioned
allene analogues of IPP were studied (Figure 1.21).71 For both IDI-1 and IDI-2, the
above proceeds through a carbocation) and IDI-2 indicates that a radical mechanism is 
not probable.
Another experiment with an IPP analogue demonstrated that the IDI-2 reaction is 
stepwise, rather than concerted with a late transition state. The vinyl thioether analogue 
(Figure 1.21) was found to exchange hydrogens at the methylene group with deuterium 
from the solvent (D2O), with little detectable isomerized product.72 Thus, the reaction of 
the vinyl thioether analogue to the carbocation was fast relative to the formation of the 
allylic isomer, and the IDI-2 reaction was stepwise.
Despite cumulative evidence that supports a carbocationic mechanism for the 
isomerization reaction, the role o f flavin was still not resolved. Crystal structures o f S. 
shibitae IDI-2 revealed that there were no residues that could function as a general acid 
or base for the respective proton addition and elimination off the substrate.73
Some recent mechanistic proposals suggested the N1/N5 nitrogens of flavin were 
general acids and O4 oxygen/N5 nitrogen were general bases for the isomerization 
because of their distance from the C4/C2 carbons of IPP, respectively.58,73 However, 
Kittleman, et al. showed that apo-IDI-2 reconstituted with 1-deazaFMN retained full 
activity.64 Since 1,5-dihydro-1-deazaFMN is not a preferred tautomer,74 the N1 nitrogen 
is likely not the catalytic acid in IDI-2. A reduced, 5,5-zwitterionic flavin has been 
proposed by our group63,68 as the general acid and is supported by the positioning of IPP 
in the IDI-2 active site.73 The protonation at N5 of anionic reduced flavin has an 
estimated p^a of ~ 4, raising the possibility of acid-base chemistry at N5.75 Hemmi and 
coworkers then proposed that the flavin N5 position acts first as the general acid donating 
a proton to C4 of IPP, followed by deprotonation at C2 of IPP by flavin’s N5 nitrogen
22
without any amino acid support (Figure 1.22.A).73 While Liu and coworkers proposed 
flavin acting as both the general acid and base, their proposal required an active site 
amino acid to act as an intermediary in proton exchange (Figure 1.22.B).66,76 However, a 
threonine to alanine mutation still retained ~ 6 % of the WT activity.73
Liu and co-workers evaluated linear free energy relationships in IDI-2 by 
changing the methyl substituents at the flavin 7 and 8 positions with electron 
withdrawing and donating groups. They found a slope of — 2 in the Hammett plot, 
indication that the rate limiting step in catalysis results in a decrease of the flavin electron 
density.76 The same group explored chiral methyl analysis of the IDI-2 mechanism and 
found the strongest evidence to date that FMN is the proton donor that results in the 
substrate carbocation.62 Based on structural models of IDI-2 with substrate bound, the
23






Figure 1.22. Proposed mechanisms of IDI-2. A, Flavin as both acid and base; B, 
Active site amino acid or water as the acid and flavin as the base.
suprafacial stereoselectivity observed in the chiral methyl analysis (described above, 
Figure 1.19) is consistent with FMN as the proton donor.
Another role for flavin is stabilization of the carbocation intermediate during 
catalysis. A delocalized HOMO surrounds the C4a-position of flavin when in the anionic 
reduced state,77 which was the same flavin state of reduced FMN bound IDI-2 before 
addition of substrate. In support of the calculated HOMO, adduct formation of IPP 
analogues (vinyl-IPP and oxiranyl-IPP, Figure 1.21) occurs at the C4a-position.58 Likely 
the tertiary carbocation intermediate is stabilized by the C4a-position during catalysis.
Despite these proposals and evidence of N5 involvement in catalysis, there is no 
definitive experimental evidence for the reduced 5,5-zwitterion of flavin. Importantly, the 
source of the proton that initiates catalysis is still unknown. Additionally, theoretical 
simulations evaluating the one- and two-electron reduction of lumiflavin have not yet 
explored the N5 protonation of anionic reduced flavin.78
Flavin Cofactors
Flavin cofactors are ubiquitous throughout nature and serve as protein structural 
stabilizers, light sensors, and catalysts. In general, there are three forms of flavin found in 
nature: riboflavin, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) 
(Figure 1.23). The conjugated ring system of flavin’s isoalloxazine molecule gives a 
unique absorbance spectrum dependent on the redox state of flavin. The cofactor readily 
undergoes reversible reduction/oxidation reactions that involve 1 or 2 e-. The major 
species of the flavin reduction pathway are shown in Figure 1.24 starting with oxidized 
flavin. With an E  = -313 mV at 20°C for FMN, the first one-electron reduction yields a 











Figure 1.23. Flavin structure and isoalloxazine ring numbering with explanation of 
different R groups.
~ 8.5.65 Abstraction of this proton results in the anionic flavin semiquinone (also called 
red semiquinone). The neutral semiquinone can be further reduced by a single electron (E 
= -101 mV for FMN), to yield the reduced anionic form of flavin. Addition of a proton 
gives fully reduced flavin, which exists in the 1,5-dihydro or the zwitterionic 5,5-dihydro 
form, where the N5 proton has a pKa of 6.7 or ~ 4, respectively.75 In a two-electron 
reduction, such as a hydride transfer from the electron donor reduced nicotinamide 
adenine dinucleotide phosphate (NADPH), oxidized flavin is converted directly to 
reduced flavin with E  = -207 mV for FMN. The redox potential of protein bound FMN 
(or FAD) can shift depending on how the cofactor is stabilized in the unique binding 
environment of the protein (because of the wide variety of flavoproteins,79 a treatment of 
redox changes upon protein binding is not appropriate for this introduction).
The species highlighted in Figure 1.24, except those for fully reduced flavin, are
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Figure 1.24. Flavin redox cycle, starting with fully oxidized flavin.
all stabilized by glucose oxidase and their corresponding absorbance spectra are shown in 
Figure 1.25.80 The 1,5-dihydro species gives a spectrum similar to anionic reduced flavin, 
except the peak at ~ 350 nm shifts to a shoulder at 400 nm. The absorbance spectrum for 
the zwitterionic reduced flavin has not been determined. Fluorescent spectra of different 
flavin species are not as distinctive as their UV-vis spectra. Generally, oxidized flavin is 
fluorescent, while the neutral and cationic semiquinone, and anionic and neutral reduced 
flavin are nonfluorescent under ambient conditions.81 In solution, free FMN and FAD 
(absorption Xmax 445 and 450 nm, respectively) both have fluorescence maxima at 525 
nm with quantum efficiencies of 0.27 and 0.032, respectively.82 For oxidized flavo- 
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Figure 1.25. Representative UV-vis spectra of glucose oxidase with flavin in the 
oxidized (yellow), anionic semiquinone (red), neutral semiquinone (light blue) and 
anionic reduced (black) oxidation states. Data extracted from reference 80, Figure 3 
with UN-SCAN-IT software.83
form.82 Evidence for strong fluorescence from reduced flavins has been investigated,84,85 
but further literature is lacking, presumably because of experimental difficulties 
stemming from the oxygen sensitivity of reduced flavins.86 Recently, the fluorescence 
emission spectra for both neutral and anionic flavin semiquinone were reported by Zhong 
and co-workers.87 Table 1.1 shows a summary of fluorescence properties for flavin states 
other than the oxidized form.
Traditionally, flavin was implicated as the cofactor in phototropic biological 
processes,88 which was recently shown to be true for the LOV (light, oxygen, voltage) 
domain protein.89 In addition, two other photoreceptor proteins use flavin as a cofactor, 
the cryptochromes90 and the recently discovered BLUF domain proteins.91,92 Prior to the 
discovery of these proteins, chemical research involved both experimental and theoretical
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Table 1.1. Summary of reduced and radical flavin cofactor absorption (excitation) 
and corresponding fluorescence emission properties.
Absorbance Fluorescence
Enzyme Cofactor Redox State Xmax (nm) Xmax (nm)
Free in solution87 FAD Anionic Reduced 2560 4 55
Free in solution87 FAD Neutral Reduced 360 480
Flavodoxin84 FMN Anionic Reduced 365 530
Lactate oxidase84 FMN Anionic Reduced 360 507
Photolyase87 FAD Anionic Reduced 360 515 and 540
L-Amino acid oxidase84 FAD Neutral Reduced 450 520
Type I cryptochrome87 FAD Anionic Semiquinone 420 513
Flavodoxin mutant87 FMN Neutral Semiquinone 580 700
Photolyase87 FAD Neutral Semiquinone 580 715
studies of the excited state of flavins outside of a biological system. The discovery of 
photoreceptors prompted a revival of chemical and biological studies relevant to flavin 
photochemistry (the unique circumstances of FAD where the adenine moiety interacts 
with flavin93,94 will not be addressed in this discussion).
Upon photoexcitation, flavin (Fl) undergoes a transition. The possibility of
a n ^ n *  transition is hidden because of the high molar absorptivities (> 104 M-1 cm-1) of 
the absorption peaks in Figure 1.25 (oxidized, yellow line), along with two other peaks at 
265 and 220 nm not shown in Figure 1.25.95 The singlet state of flavin (1Fl) has a lifetime 
of ~ 4.5 ns,96 decaying to the triplet state (3Fl) which has a lifetime of ~ 204 p,s.97 
Intersystem crossing from 1Fl to 3Fl is highly efficient, with O = 0.7, while 3Fl 
phosphorescence emission is quite inefficient, Op = 0.0012, indicating that the triplet state 
decays through nonradiative relaxation.95 The longer-lived and highly populated 3Fl acts 
as a strong oxidant with the capacity to abstract a hydrogen or to undergo a 2e- transfer
reaction resulting in the ground state reduced flavin (see Eqs. 1.1 -  1.5 in Table 1.2). In 
addition to the reactions in Table 1.2, 3Fl can undergo photodealkylation, photooxidation, 
and both inter- and intraphotoaddition reactions.98 Equations 1.1 -  1.3 are characteristic 
of D-D reactions of dye molecules, while equations 1.4 and 1.5 tend to be more common 
among flavins than other dyes.99
The formation of flavin semiquinone (Eq. 1.2, reverse reaction) was exploited 
with flavoproteins to yield enzyme stabilized flavin semiquinone using free flavin 
(synthetic analogues and natural forms) as a catalyst (see Eqs. 1.6 -  1.9 in Table 1.2).100 
Note that flavin is first photoreduced using EDTA as a photosubstrate and the following 
enzymatic reactions take place in the dark. With this technique, Massey, et al. were able 
to demonstrate that if an enzyme could stabilize flavin semiquinone, the reduction either 
stops with Eq. 1.7 or slowly proceeds to the fully reduced form (Eq. 1.8). As a special 
case, Massey and Hemmerich found that 5-carba-5-deazaflavins (deazaflavins) proceed 
through a different catalytic path, where a dimer is formed after photoexcitation of the 
oxidized deazaflavin (contrasting Eq. 1.6 where the fully reduced flavin is formed).101
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Table 1.2. Summary of photoexcited flavin reactions.
Reduction Reaction
1e- 3Fl + HR ^  HFr + R^ 1.1
2HFK ^  Flox + H2Fl 1.2
HFr + R^  ^  HFlR 1.3
2e- 3Fl + HR ^  HFlR 1.4
3Fl + HR ^  HFl- + R 1.5
Enzyme Flox H2Fl hv
1.6
H2Fl + EFl ^  HFr + EFlH 1.7
H2Fl + E F lf f^  HFr + EFlH2 1.8
2HFr ^  Flox + H2Fl 1.9
After light exposure in the presence of a photosubstrate (EDTA or oxalate), an adduct is 
formed between C5 of the deazaflavin and the substrate. A second deaza-3Fl displaces the 
substrate and a C5-C5 bond is formed between the two deazaflavins. Subsequently, this 
bond splits, creating two radical deazaflavins. These radical deazaflavins have a low 
reduction potential (~ -650 mV) which can be exploited to reduce other biological 
cofactors such as flavins, hemes, and iron-sulfur clusters.101
Flavoenzymes have also been investigated using flavin analogues as active site 
and mechanistic probes (while there are flavin analogues with R modifications (see 
Figure 1.23), for the purposes of this presentation, only analogues with isoalloxazine 
modifications will be discussed). With the exception of an enzyme in which flavin is 
covalently bound in the active site, the noncovalently bound flavin can be removed and 
the apoenzyme reconstituted with a coenzyme analogue (note that sometimes 
reconstitution is not possible because of irreversible protein denaturation). The spectral 
changes of these active site probes have been studied in the free and protein bound forms 
(see Appendix A for some example flavin analogues and their properties). One 
commonly used analogue is 8-chloroflavin because of its reactivity with sulfur 
nucleophiles. This analogue has a dual purpose, first in identifying thiolate residues in the 
active site near the flavin 8-position (used with lipoyl dehydrogenase and electron 
transfer protein)102 and second in testing the solvent accessibility of the 8-position, both 
observable because of dramatic spectral changes from 8-chloro to 8-mercaptoflavin.80 8- 
Mercaptoflavins were used to study the redox state of flavin in numerous flavoenzymes, 
finding that the spectral and reduction properties of reconstituted enzyme mirrored that of 
the wild type (e.g., a stabilized red semiquinone flavin in the native enzyme was also
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observed with the 8-mercaptoflavoenzyme).103 In a similar way, 4-thioflavins have been 
used to study the environment around the C4 carbonyl of flavin. Massey, et al. found that
4-thioflavins were reactive both as a nucleophile and an electrophile and used this 
knowledge to study the solvent accessibility of the O4 position of flavin in several 
enzymes.104 With the increased success of crystallography, the use of flavin analogues as 
structural probes has diminished while they are still used as mechanistic probes.
As mechanistic probes, flavin analogues were used to assess the participation of 
flavin during catalysis and to alter the mechanism by using analogues with different 
reduction potentials. Both 1-carba-1-deaza- and 5-carba-5-deazaflavins (shortened to 1- 
deaza and 5-deaza, respectively, in the literature) are the most commonly used 
mechanistic probes.102 5-Deazaflavins have been used to determine whether a covalent 
intermediate exists in some proposed substrate carbanion intermediate reactions and if a 
radical flavin intermediate was involved in some reactions. In mechanisms where either 
flavin N5 or the substrate act as a nucleophile on each other, enzyme reconstituted 5- 
deazaflavin should produce a covalent adduct that can be isolated. Recently, this theory 
was applied to flavin-dependent thymidylate synthase to show the reaction proceeds 
through hydride transfer, not a covalent intermediate.105 As described next, another 
example of flavin analogues as mechanistic probes involves the use of 6- and 8-position 
substituted analogues in free-energy relationships.
Bacterial luciferase catalyzes the reaction of fully reduced FMN, O2 and a long 
chain aliphatic aldehyde to produce oxidized FMN, a carboxylic acid and emitted light. 
The reaction has been hypothesized to be a Baeyer-Villiger oxidation, typical of ketone 
monooxygenases where cyclic ketones (e.g., cyclopentanone and cyclohexanone) react
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with O2, yielding water and the related lactone. The ketone monooxygenase reaction 
proceeds through a flavin-C4a-peroxy intermediate, which acts as the nucleophile 
attacking the carbonyl carbon of the ketone.106 Francisco, et al. used six 8-substituted 
FMN analogues and transient kinetic studies to support their mechanism for 
bioluminescence by bacterial luciferase. The Hammett equation was applied to the rate of 
light decay and yielded a p = -4, which is inconsistent with a Baeyer-Villiger reaction 
expected to give p = ~ (0.2 -  0.6).107 Similar analyses have been performed on lactate 
oxidase using both 6- and 8- substituted FMN analogues108 and 2-methyl-3- 
hydroxypyridine-5-carboxylic acid oxygenase using 8-substituted FAD analogues.109
Dissertation Overview
The work that is presented within this dissertation includes qualitative (spectral) 
and quantitative (kinetic) studies with the type 2 isopentenyl diphosphate:dimethylallyl 
diphosphate isomerase (IDI-2) and statistical analysis of kinetic isotope data from 
enzymes in the isoprenoid biosynthetic pathway. Chapter 2 presents data that challenge 
earlier conclusions of flavin adducts structures formed during incubation of substrate 
analogues with IDI-2 and introduces an in-depth statistical analysis of the oxidation of an 
FMN adduct. Chapter 3 introduces evidence for formation of a flavin adduct when IDI-2 
is incubated with the natural substrates, IPP and DMAPP. Chapter 4 describes the kinetic 
mechanism of the Streptococcus pneumoniae IDI-2. To conclude, Chapter 5 gives the 
detailed statistical analysis of transient kinetic isotope effect data from farnesyl 
diphosphate synthase and protein farnesyl transferase.
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CHAPTER 2
COVALENT MODIFICATION OF THE TYPE 2 ISOPENTENYL 
DIPHOSPHATE:DIMETHYLALLYL DIPHOSHATE 
ISOMERASE FLAVIN COFACTOR WITH 
SUBSTRATE ANALOGUES
Introduction
Some substrate analogues for IDI-2 were irreversible inhibitors that formed 
covalent adducts with the flavin cofactor.68 Initially, the adducts were thought to form at 
N5 of flavin (Figure 2.1). These studies used UV-vis absorption spectroscopy and mass 
spectrometry to provide information about the adduct structures. However, the oxygen 
sensitivity o f flavin adducts was not recognized since the adducts were exposed to 
oxygen when isolated from the enzyme.
When more stringent anaerobic conditions were used, some substrate analogues 
formed adducts at the C4a-position of flavin (Figure 2.1). In this chapter, the 
spectroscopic examination of several substrate analogues will be reported. The 
spectroscopic studies include UV-vis absorption and fluorescence spectroscopy of the 
adducts under different conditions, and the UV-vis absorption of the adducts while they 
undergo oxidation.
Oxidation of the adduct formed from 3,4-oxido-3-methyl-1-butyl diphosphate 




Figure 2.1. Structures of flavin adducts. R represents the ribityl or ribityl phosphate 
chain. R 1 is a substituent at the N5-position and R2 is a substituent at the C4a- 
position.
squares (MCR-ALS) and genetic optimization using derivatives (Genoud). Multivariate 
curve resolution (MCR) is an exploratory tool that deconvolutes multicomponent spectral 
data with a time element.110 For example, data collected on an HPLC with a diode array 
detector will have an absorption spectrum at each retention time. These data can be 
imagined to have m spectra collected at n wavelengths forming a matrix Dm x n, which can 
be equated using a multivariate form of Beer's Law (Equation 2.1),
where C is a m x k  matrix representing the concentration profile of k  species for m time 
points, ST is a k  x n matrix representing the pure spectra of k  species at n wavelengths and 
E is the error matrix. With matrix algebra, the concentration profiles can be determined if 
the pure spectra are known (Equation 2.2) or if the concentration profiles are known, the 
spectra can be estimated (Equation 2.3).111
D = CST + E 2.1
C = d s (sts ) 1 
S = d tc (c tc ) -1
2.2
2.3
If the pure spectra and concentration profiles are not known, initial estimates must
be provided. Then, the data are initially fit to either equation 2.2 or 2.3 and are optimized 
using least squares. The optimization continues by application of these best fits to the 
other equation, which is then optimized using least squares. This method is iterated until 
no more significant improvement in the fit is obtained in a process called alternating least 
squares (ALS).112 In combination, MCR-ALS can resolve complex systems without any 
prior knowledge of the number of species or their pure spectra. An advantage of this 
method is the ability to uncover unknown intermediates that may be the result of 
unknown chemical pathways. However, the method may also introduce species that are 
not present, or may exaggerate certain components in the spectra that can introduce 
multimodality in the concentration profile. In addition, MCR-ALS ignores chemical 
kinetics. However, if the concentration profile represents a chemical process, it can be fit 
to a series of differential equations to determine kinetic rates.
The concentration profile described above may be quite complex as the number of 
species and rates increases. An added complexity is the optimization of the parameter 
values to fit such a complex system of simultaneous differential equations. Traditional 
optimization routines rely on starting or seed values and then explore the region of 
sample space surrounding those values with a Newton-type method (an explanation of 
these are beyond the scope of this chapter, however can be found in Seber and Wild).113 
The sample space may be exceedingly large for multiple parameter models. Thus if seed 
values are chosen far from the optimum the algorithm may never converge on a solution. 
Application of an evolutionary algorithm can be a solution to difficult optimizations. 
Given a population of values (the parents), the algorithm applies heuristic rules to adapt 
these values so that over the entire population, the adapted values (the children) are better
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than the parents.114 Some of these rules include copying a subset of the population, 
applying mutations (one example is picking a random number between the lower and 
upper bounds of a random subset of the population) and crossovers (one example is the 
random swapping of parameter values between two members of the population).114 The 
approach is one of brute force exploration of the sample space and requires a significant 
amount o f computation. However, the method is meant to search the sample space in a 
manner more appropriate than random exploration. With a large population of values, the 
true optimum is more likely to be found.
Experimental Procedures
Materials. Racemic 3-oxiranyl-3-buten-1-yl diphosphate (oIPP), 3-cyclopropyl-3- 
buten-1-yl diphosphate (cIPP), 3-fluoromethyl-3-buten-1-yl diphosphate (fmIPP), (R)- 
and (S)-2-fluoro-3-methyl-3-buten-1-yl diphosphate (R-2fIPP and S-2fIPP, respectively), 
racemic 3,4-oxido-3-methyl-1-butyl diphosphate (eIPP) and 3-methylene-4-penten-1-yl 
diphosphate (vIPP) were available from previous studies (Figure 2.2).55,68 Glycerol and 
guanidineHCl were from USB Corporation. Tryptone and K2HPO4 were from Fisher 
Scientific and yeast extract was from BD Biosciences. KH2PO4 was from Mallinckrodt. 
Other reagents are from Sigma-Aldrich unless noted.
Expression and purification. His-tagged IDI-2 from Thermus thermophilus was 
expressed in Escherichia coli and purified as previously described58,63 or was slightly 
modified as follows. Terrific broth stock (12 g tryptone with 24 g yeast extract in 900 mL 
H2O) was supplemented with 0.2 g/L riboflavin. Terrific broth was prepared with 100 mL 
of a salt solution (170 mM KH2PO4 with 720 mM K2HPO4) and 900 mL of the Terrific 
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Figure 2.2. Structures of IPP analogues used in adduct formation studies.
to a final concentration of 100 |ig/mL and 34 |ig/mL, respectively. The culture was 
grown at 37 °C for 4 h, and then induced with IPTG that contained FMN (final 
concentration 0.4 mM IPTG and 40 |ig/mL FMN). After 4 h the cultures were harvested 
and yielded 4.3 g of cell paste per liter of media.
The only modifications to purification used a GE HisTrap HP column with a flow 
rate of ~5 mL/min, and the enzyme was with 500 mM imidazole (Acros) in 50 mM of 
Na2HPO4 (Mallinckrodt) pH 8, containing 300 mM NaCl (Mallinckrodt).
UV-vis assays. Assays were performed as previously described,58,68 with the
following modifications. At least 7 d before running an assay, all reagents were made O2- 
free through gas exchange for one h (degassed under vacuum and then purged with 
argon), and then put into an anaerobic chamber (< 5 ppm O2) (Coy Laboratories). IDI-2 
and the respective substrate/inhibitor were gas exchanged and placed in the anaerobic 
chamber the day of experimentation. Reaction mixtures contained: 100 |iM flavin-bound 
IDI-2 in 200 mM HEPES buffer, pH 7.0 (at 37 °C), containing 2 mM MgCh, 8 mM 
Na2S2O4 and 400-800 |iM substrate/inhibitor. After a minimum incubation of 4 h (or 
overnight) at 37 °C in the anaerobic chamber, samples were washed three times with 25 
mM NH4HCO3, pH 7.8 at 20 °C in the anaerobic chamber through a Microcon 30 KDa 
MWCO ultrafiltration device to remove small molecules (Amicon/Millipore). Samples 
with enzyme were diluted to a final concentration of 10 mM NH4HCO3 buffer, pH 7.8 
containing 5 % glycerol. Samples denatured with 8 M guanidine in 20 mM sodium 
phosphate, pH 6 or 7, were filtered (with an ultrafiltration device) to separate the protein 
from the adduct, and then diluted with denaturant. Samples denatured with 6 N HCl were 
centrifuged (without ultrafiltration) to separate protein precipitate from the adduct. The 
supernatant was removed and diluted with additional 6 N HCl for measurement. Samples 
were prepared in a twist-top cuvette (Starna Cells) and sealed with a Thermogreen™ LB-2 
septum (Supelco) prior to removal from the anaerobic chamber. For oxidation studies, the 
cuvette was opened and the sample exposed to air by diffusion, with mixing using a stir 
bar (with the Agilent peltier attachment), vigorously shaking the cuvette, or pipetting air 
into the sample. UV-vis absorption measurements were made using an Agilent 8453 
diode array spectrophotometer or Beckman Coulter DU730.
Fluorescence assays. Substrate analogue adducts were prepared as described
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above for the UV-vis assays. After adducts were prepared, they were diluted to a 
concentration of 10 |iM with denaturant or for enzyme-bound adducts with 5 % glycerol. 
For measurements with only IDI-2 (no analogues), assays contained: 10 |iM flavin-bound 
IDI-2 in fluorescence assay buffer (200 mM HEPES buffer, pH 7.0, (at 37 °C), containing 
5 % glycerol and 2 mM MgCh). For reduced samples, Na2S2O4 was added to a final 
concentration of 0.8 mM. For some samples, IPP was added to a final concentration of 
100 |iM. Control reactions of FMNox and FMNred contained 10 |iM FMN in fluorescence 
assay buffer, with dithionite added to the FMNred control. Fluorescence measurements 
were made using a Horiba Jobin Yvon FluoroMax-3.
Analysis o f eIPP oxidation pathway. The oxidation of the eIPP-adduct was 
modeled with a multivariate curve resolution-alternating least squares (MCR-ALS) 
analysis to estimate the time course of the flavin oxidation and to determine the spectrum 
of any unknown intermediates. Reference spectra were created from the initial spectrum 
collected at time zero (for the eIPP-adduct), the spectrum with the maximum absorbance 
at 600 nm (at 36.5 min, for the radical adduct), and the last spectrum that represented the 
final product (oxidized FMN). Unknown intermediates were assigned an arbitrary 
constant spectrum for all time points (absorbance = 1.0). Total flavin concentration (TFC) 
was determined based on the absorption of the spectrum for the fully oxidized FMN 
species and a reference extinction coefficient of 12,200 M-1 cm-1 at X450.115 The initial 
concentration matrix was designed as shown in Table 2.1 for any number of rows.
The oxidation rates were determined for the simplified oxidation pathway in 
Table 2.2 based on the time course determined in the MCR-ALS analysis. Parameter 
estimates were supllied to differential equations that described Table 2.2 and used to
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Table 2.1. Design of the initial concentration matrix for the MCR-ALS analysis. 







TFC 0 0 0
0 TFC 0 0
0 TFC 0 0
0 0 TFC 0
0 0 TFC 0
0 0 0 TFC
0 0 0 TFC
Table 2.2. Photooxidation reactions used to model the eIPP-FMN adduct oxidation 
where adduct formation occurs at the N5-position of flavin.
5-RFlredH + O2 ^  5-RFlox' + HO2-, ki 2.4 
5-RFlredH + 5-RFlox+ ^  2  5-RFK + H+, k2 2.5
5-RFr + O2 ^  5-RFlox+ + O2 -, k3 2.6
5-RFlox+ + OH- ^  Flox + ROH, k4___________________ 2.7
calculate the concentration of the flavin species. The squares of the difference between 
these calculated values and the values determined with MCR-ALS for each species were 
summed. This sum of squares value was minimized with genetic optimization using 
derivatives (Genoud),116 where all rate constants, as well as [O2] were allowed to float 
within the boundary conditions shown in Table 2.3.
Analyses for the above statistical techniques were performed using R version
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Table 2.3. Boundary conditions applied to genoud algorithm.
Parameter Lower Upper
k1 1 x 10-5 1 x 103
k2 1 x 102 1 x 108
k3 1 x 10-4 1 x 103
k4 1 x 10-3 0.1
[O2] 1 x 10-6 0.1
3.0.0 or later117 using the packages ALS,118 nnls,119 Iso,120 dichromat,121 rgenoud,114 
nlmeODE,122 deSolve,123 nlme,124 and lattice.125
Results
UV-vis spectroscopy o f adducts. Three approaches were applied to determine the 
bond position of a flavin adduct. First the enzyme-bound adduct was studied and 
compared to both FMN*IDI-2 and IPP*FMN*IDI-2. Next, denaturation was performed 
with guanidine at neutral pH (6 or 7) and with 6 N HCl. The difference between the 
spectra collected at neutral pH versus a very low pH, along with the oxidation pathway of 
that isolated adduct can identify whether adduct formation occurs at the N5- or C4a- 
position (Table 2.4).
Table 2.4. Published trends for flavin adducts.126129
C4a-Adduct N5-Adduct
Neutral pH, Xmax (nm) 360 -  370 and ~ 300sh 296 -  300
6 N HCl, Xmax (nm) ~ 400 < 300
Oxidation Requires: O2 + Light
Only O2 (dark 
oxidation possible)
Adduct ->
Oxidation Pathway Adduct ^  Flavinoxidized Radical Intermediate ->
Flavinoxidized
Fluorescence Emission, 475 530Xmax (nm)
The results for vIPP, oIPP, eIPP and fmIPP analogues are in Table 2.5. After a 24 
h incubation, the spectrum of each analogue incubated with enzyme differed from the 
spectrum of FMNred*IDI-2. Furthermore, each spectrum was different from the initial 
spectrum when IPP was added to FMNred*IDI-2 (Figure 2.3). The results for vIPP, oIPP, 
and fmIPP were similar at neutral pH (peak maxima ~365 -  375 nm and a shoulder at 
~302 nm, Figure 2.4) and in 6 N HCl (peak maxima at ~ 400 nm, Figure 2.5). This 
bathochromic shift in the absorption maxima from a neutral to low pH was characteristic 
of a C4a-adduct. For eIPP, the spectrum at neutral pH has a shoulder at 324 nm that may 
represent a maximum. After isolation with 6 N HCl this peak at 324 nm shifted to a 
shoulder at 298 nm, a hypsochromic shift that indicated an N5-adduct. Both Figure 2.4
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Table 2.5. UV-vis absorption properties of FMN adducts formed from IPP 




Condition Maxima (nm) Minima (nm) Shoulders
Enzyme No Substrate 352 325
Reference (no
incubation) IPP 430 367 316
vIPP 404 353 315
oIPP 342 313 416
Enzyme-bound
eIPP 350 314 -
fmIPP 417 (broad) 393 308
vIPP 256, 364 247, 331 303
8 M guanidine, oIPP 278, 375 259, 333 303
pH 6 eIPP 258 239 304, 324, 378
fmIPP 278, 374 257, 332 302
vIPP 267, 402 259, 357 302
oIPP 272, 305, 402 255, 300, 353 -
6 N HCl
eIPP 283, 395, 481 261, 384, 448 248, 298, 356
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Figure 2.3. UV-vis absorption spectra of IDI-2 bound IPP analogue adducts. Lines 
represent vIPP- (cyan), oIPP- (magenta), eIPP- (red), and fmIPP- (green) adducts, 
as well as FMNred^IDI-2 (black) and IPP^FMNred^IDI-2 (brown). Spectra were 
normalized for absorption at 280 nm.
and Figure 2.5 have an inset displaying a small contribution from a radical species 
present in the eIPP spectra.
There are two characteristics of adducts that can be evaluated by observation of 
their oxidation pathway (Table 2.4). First, N5-adducts are O2 sensitive, but C4a-adducts 
are stable after O2 exposure until exposed to light. Second, N5-adducts oxidize through a 
radical intermediate detectable by an increase in absorption at 600 or 510 nm (at neutral 
pH or 6 N HCl, respectively), while C4a-adducts oxidize directly to the oxidized flavin 
species.126 Oxidation of the vIPP-adduct is shown in Figure 2.6.A. In the first 4 min, the 
absorbance changed with isosbestic points at 276, 321, 368 and 415 nm, with increases in 
absorbance at 360 and 445 nm, characteristic of oxidized flavin. After oxidized flavin 
was formed, the absorbance at 445 nm decreased, likely because of photodegradation.
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Figure 2.4. UV-vis absorption spectra of free adducts in 8 M guanidine, pH 6. Lines 
represent vIPP- (cyan), oIPP- (magenta), eIPP- (red), and fmIPP- (green) adducts. 
Inset highlights the presence of a radical species in the eIPP-adduct spectrum. 
Spectra were normalized for absorption at 231 nm (a common peak beyond the 
scale of interest).
Importantly there is no indication of a radical intermediate and no spectral change was 
observed when the sample was exposed to air in the absence of light. When the vIPP- 
adduct was oxidized in 6 N HCl, absorption peaks at ~ 270 and 400 nm increased for the 
first 35 min of photooxidation with isosbestic points around 290 and 320 nm (Figure 
2.6.B). The pathway then proceeded through isosbestic points at 276 and 342 nm with a 
peak that appeared at 294 nm and the peak at ~ 400 nm shifted a few nanometers. The 
observed pattern matched that of a 4a-alkylated lumiflavin analogue photooxidized in 6 N 
HCl that resulted in protonated oxidized flavin with a sharp peak maximum at 395 nm.128
The oxidation pathway of the oIPP-adduct in pH 6 (Figure 2.7.A) was similar to 
that of vIPP-adduct oxidation under the same conditions. In the first 10 min, there were 
increases in absorption at ~ 360 and 445 nm with isosbestic points at 274, 318 and 415
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Figure 2.5. UV-vis absorption spectra of free adducts in 6 N HC1. Lines represent 
vIPP- (cyan), oIPP- (magenta), eIPP- (red), and fmIPP- (green) adducts. Inset 
highlights the presence of a radical species in the eIPP-adduct spectrum. Spectra 
were normalized for absorption at 300 nm (a common peak/shoulder).
nm. After 10 min, absorption continued to increase without any significant spectral 
changes. As with the vIPP-adduct, there was no evidence for a radical intermediate and 
light was required. For the oIPP-adduct oxidation in 6 N HCl (Figure 2.7.B), there was a 
slight increase in absorption at ~ 500 nm, possibly indicating a radical intermediate. 
Otherwise the spectral changes were similar to those of the vIPP-adduct. There is no clear 
isosbestic point that led to the ~ 500 nm peak and importantly, the protonated N5- 
alkylated flavin intermediate has a sharp peak at ~ 500 nm.128,130 Thus, the observed 
species is likely a small proportion of N5-adduct or some unknown intermediate.
Oxidation of the eIPP-adduct is unique from the other oxidation pathways 
because light was not necessary to observe a spectral change. At pH 6, the oxidation 
proceeded through a radical intermediate detected by a broad peak around 600 nm
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Figure 2.6. UV-vis absorption spectra of vIPP-adduct oxidation. A, In 8 M 
guanidine, pH 6; B, In 6 N HCl. Time represents the amount of time exposed to 
light. Modified from reference 58.
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Figure 2.7. UV-vis absorption spectra of oIPP-adduct oxidation. A, In 8 M 
guanidine, pH 6; B, In 6 N HCl. Time represents the amount of time exposed to 
light.
(Figure 2.8.A), followed by further oxidation of the intermediate giving isosbestic points 
at 302, 350 and 500 nm, and finally producing fully oxidized flavin with peaks at 375 and 
445 nm (Figure 2.8.B). A similar pattern was observed for the oxidation in 6 N HCl. A 
radical intermediate formed through a series of spectra with an isosbestic point at 320 
nm, and a final spectrum for the radical with peaks at 355, 396 and 510 nm (Figure 
2.9.A). After formation of the radical intermediate, oxidation continued with isosbestic 
points at 280, 360 and 445 nm to give a spectrum of protonated fully oxidized flavin 
product with a peak at 396 nm (Figure 2.9.B).
Photooxidation of the fmIPP-adduct at pH 6 produced a spectrum of fully 
oxidized FMN (Figure 2.10.A). For this experiment, the sample was exposed to O2 (air) 
for almost 6 h before light exposure. For clarity, only the initial (no O2) and final (5.8 h 
of exposure to air) spectra are shown in Figure 2.10.A. Only a small increase in 
absorption was observed at 600 nm, which may have been caused by residual light in the 
laboratory and is not considered significant. Once the sample was exposed to light, the 
sample rapidly oxidized in 35 min to give fully oxidized FMN, without evidence for 
formation of a radical intermediate. Spectra gave two isosbestic points at 290 and 329 nm 
during this photooxidation. The final spectrum for fully oxidized flavin had peaks at 375 
and 445 nm.
In the absence of light, oxidation of the fmIPP-adduct in 6 N HCl gave a radical 
intermediate that was photooxidized to protonated oxidized flavin (Figure 2.11.A and .B). 
In the absence of light, the radical slowly formed over a period of 19 h with poorly 
defined isosbestic points at ~ 340 and ~ 450 nm (Figure 2.11.A). Peaks seen at 358 and 
505 nm were characteristic of a protonated N5-alkylated flavin.130 The radical was then
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Figure 2.8. UV-vis absorption spectra of eIPP-adduct oxidation in 8 M guanidine, 
pH 6. A, Displaying the absorption change leading to the intermediate; B, 
Continuation of A, from the intermediate to product. Time represents the amount of 
time exposed to oxygen.
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Figure 2.9. UV-vis absorption spectra of eIPP-adduct oxidation in 6 N HCl. A, 
Displaying the absorption change leading to the intermediate; B, Continuation of A, 
from the intermediate to product. Time represents the amount of time exposed to 
oxygen.
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Figure 2.10. UV-vis absorption spectra of fmIPP-adduct oxidation in 8 M guanidine, 
pH 6.
slowly photooxidized and gave a series of spectra with well-defined isosbestic points at 
293, 356 and 445 nm and a final spectrum with a peak at 395 nm, characteristic of a 
protonated fully oxidized flavin product (Figure 2.11.B). For the fmIPP-adduct, the 
oxidation results were inconsistent and present an argument against reliance on just one 
type of spectral evidence to conclude the position of flavin adduct formation.
Fluorescence spectroscopy o f adducts. In solution, free FMNox has a fluorescence 
emission maximum at 525 nm and oxidized flavoproteins have similar fluorescence 
properties.82 Evidence for strong fluorescence from reduced flavins has been 
investigated,84,85 but further literature is lacking, presumably because of experimental 
difficulties that stem from the oxygen sensitivity o f reduced flavins and the need for low 
temperatures (77 K).86 The fluorescence emission spectra for both neutral and anionic 
flavin semiquinone were reported by Zhong and co-workers (Table 1.1).87
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Figure 2.11. UV-vis absorption spectra of fmIPP-adduct oxidation in 6 N HCl. A, 
Oxidation in the absence of light; B, Continuation of A, after light exposure.
The emission spectra of a flavin adduct differs whether the bond occurs at N5 or 
C4a. However literature on the subject is scant. One of the few examples studied adducts 
isolated from lactate oxidase at 293 K and demonstrated that N5- and C4a-adducts have a 
fluorescence maximum at ~ 475 and 530 nm, respectively.85 Only the adducts formed 
from vIPP, oIPP and eIPP were measured with fluorescence. For comparison, the 
fluorescence properties of IDI-2 were evaluated and are presented first.
As a control, the emission maximum for FMNox was confirmed to be 528 nm 
without any other unique characteristics. However, for FMNox‘IDI-2, a peak at 660 nm 
was very intense in the presence or absence of IPP (Table 2.6 and Figure 2.12). When 
reduced, this peak shifted to 700 nm and the intensity diminished by about 96 %.
When emission at 530 nm was monitored, IPP*FMNred*IDI-2 had a poorly defined 
excitation maximum at ~ 418 nm (Figure 2.13.A), similar to the absorption maximum at 
426 nm (Figure 2.3). Excitation at 420 nm, gave an emission maximum at 540 nm 
(Figure 2.13.B). Interestingly, emission from the reduced state in the presence of IPP was 
about five times more intense than from the oxidized form of the enzyme.
Fluorescence spectra were collected for flavin adducts bound to IDI-2, and free 
from enzyme by denaturation of the complex with 8 M  guanidine, pH 7 or by 6 N HCl 
(Table 2.7). Excitation of enzyme-bound adducts at 295 nm yielded similar results to
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e^xcite 295 nm Xexcite 420 nm
None 348 660 520
Oxidized
IPP 354 660 515
None 366 700 515
Reduced
IPP 418 538, 700 540
54
Emission Wavelength (nm)
Figure 2.12. Fluorescence emission spectra with excitation at 295 nm of 7if-IDI-2 
under various conditions. Inset is scaled in to highlight the characteristics of the less 
intense spectra. Lines represent: FMNox (green), FMNred (yellow), FMNox^IDI-2 
(black), IPP^FMNox^IDI-2 (purple), FMNred^IDI-2 (blue), IPP^FMNred^IDI-2 (red). 
Note: sharp peaks in around 580 nm are Raman peaks for water.
FMNox‘IDI-2, where a very intense emission was seen at 660 nm. Additionally, the vIPP- 
adduct had a shallow peak at 523 nm and the eIPP-adduct had an intense peak at 470 nm 
(Figure 2.14.A). In 8 M guanidine, pH 7, each adduct fluoresced at ~ 530 nm with a 
second peak at ~ 664 nm that overlapped with a Raman peak from water (Figure 2.14.B). 
For the spectra in 6 N HCl, each adduct fluoresced at 460 nm. However these peaks were 
not considered significant because of their low intensity (Figure 2.14.C).
Additional emission spectra were collected with excitation at 350 nm, which was 
an excitation maximum for FMNox*IDI-2 when emission was monitored at 530 nm 
(Figure 2.12.B). With 350 nm excitation, enzyme-bound adducts fluoresced at ~ 450 -  
470 nm, and were intense compared to the FMNred*IDI-2 and IPP*FMNred*IDI-2 species 
(Figure 2.15.A). The adducts in pH 7 each fluoresced at 530 nm with a smaller peak at
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Figure 2.13. Fluorescence excitation spectra of 7MDI-2 under various conditions. A, 
Monitoring emission intensity at 530 nm (FMNox spectrum decreased 85 %); B, 
Emission spectrum with excitation at 420 nm (FMNox spectrum normalized to have 
the same peak height as IPP^FMNred^IDI-2, ~ 87% decrease). Lines represent: 
FMNox (green), FMNred (yellow), FMNox^IDI-2 (black), IPP^FMNox^IDI-2 (purple), 
FMNred^IDI-2 (blue), IPP^FMNred^IDI-2 (red).
56
Table 2.7. Fluorescence properties of adducts formed from substrate analogues.
Condition
Substrate
Analogue e^xcite = 295 nm
Emission Xmax (nm) 
e^xcite 350 nm Xexcite 420 nm
vIPP 523, 664 450 537
Bound oIPP 664 457 525
eIPP 470, 664 470 475
vIPP 531, ~664 430, 530 529
pH 7 oIPP 537, ~664 435, 530 530r
eIPP 528, ~664 432, 531 533
vIPP 460 453 ~460
6 N HCl oIPP 460 451 553
eIPP 460 452 -
~ 430 nm. Control spectra were collected for FMNox and FMNred at pH 7, with excitation 
at 350 nm and they fluoresced at ~ 430 and 530 nm, respectively (Figure 2.15.B). It 
appears that the adducts possess characteristics of both flavin redox species, which would 
indicate that the adducts were a population of both N5- and C4a-adducts. In 6 N HCl 
(Figure 2.15.C), the peak intensities were ~ 1 % or less than the most intense peak 
observed at 350 nm excitation and were not considered significant.
The emission seen upon excitation at 420 nm revealed an important difference 
between the vIPP- and oIPP-bound adducts and the eIPP-bound adduct. Emission 
maxima for vIPP and oIPP were observed at ~530 nm, while the eIPP maximum was 475 
nm (Figure 2.16.A). These values correspond to C4a- (530 nm) and N5- (475 nm) 
adducts as observed for a C4a-adduct in D-amino acid oxidase and an N5-adduct in 
lactate oxidase.84 Contrary to the enzyme-bound observations, when these adducts were 
isolated and measured in pH 7, each fluoresced at ~ 530 nm. The fluorescence spectra 
collected for the adducts in 6 N HCl have an insignificantly small intensity (Figure 
2.16.C).
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Figure 2.14. Fluorescence spectra of Tt-IDI-2 adducts formed from substrate 
analogues under various conditions with excitation at 295 nm. A, Emission spectra 
of bound adduct; B, Emission spectra of adduct isolated with 8 M guanidine, pH 7; 
C, Emission spectra of adduct isolated with 6 N HCl. Lines represent: vIPP- (cyan), 
oIPP- (magenta), and eIPP- (red) adducts.
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Figure 2.15. Fluorescence spectra of 7MDI-2 adducts formed from substrate 
analogues under various conditions with excitation at 350 nm. A, Emission spectra 
of bound adduct with FMNred^IDI-2 (black) and FMNred^IDI-2^IPP (blue); B, 
Emission spectra of adducts isolated with 8 M guanidine, pH 7 with FMNred (yellow) 
and FMNox (green) (spectrum decreased by 80 %); C, Emission spectra of adduct 
isolated with 6 N HCl. Lines represent: vIPP- (cyan), oIPP- (magenta), and eIPP- 
(red) adducts.
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Figure 2.16. Fluorescence spectra of 7MDI-2 adducts formed from substrate 
analogues under various conditions with excitation at 420 nm. A, Emission spectra 
of bound adduct; B, Emission spectra of adduct isolated with 8 M guanidine, pH 7; 
C, Emission spectra of adduct isolated with 6 N HCl. Lines represent: vIPP- (cyan), 
oIPP- (magenta), and eIPP- (red) adducts.
UV-vis spectroscopy o f non-adduct forming substrate analogues. In addition to 
the analogues described above, other substrate analogues did not show evidence of 
adduct formation. The (R)- and (S)-2fIPP compounds were not irreversible inhibitors for 
IDI-1.55 cIPP was an alternate substrate for IDI-2 and did not covalently modify the 
flavin cofactor as determined by mass spectrometry (Figure 2.17).68 For these 
compounds, UV-vis absorption assays provided sufficient evidence that adduct formation 
did not occur.
After a 24 h incubation, the enzyme was washed with buffer and the collected 
spectrum for each analogue was similar to that of FMNred*IDI-2 (Figure 2.18 and Table
2.8). The (R)- and (S)-2fIPP analogues were further evaluated with guanidine 
denaturation. The spectra of the isolated flavin product resemble that of neutral reduced 
flavin with shoulders at ~ 280 and ~ 400 nm (Figure 2.19).130 The products isolated by 
denaturation with 6 N HCl resemble protonated radical flavin with peaks at 258, 358, and 
488 nm (Figure 2.20).130 Based on the other spectral evidence, the partial oxidation in 6 N 
HCl was not likely the result of degradation of an N5-adduct, but rather an artifact due to 
the long-lived radical stabilized in 6 N HCl as observed in Figure 2.9 for the degradation 
of the eIPP-adduct.
Analysis o f eIPP oxidation pathway. The oxidation pathway of the eIPP-adduct 
isolated with guanidine (Figure 2.8) was modeled with MCR-ALS to determine the
60
R-2flPP S-2flPP cIPP








o  ------ 1------ 1------ i i I I I -
300 400 500 600 
Wavelength (nm)
Figure 2.18. UV-vis absorption spectra of IDI-2 bound IPP analogues. Lines 
represent R-2fIPP (dark green), S-2fIPP (purple), cIPP (yellow), FMNred^IDI-2 
(black) and IPP^FMNred^IDI-2 (brown). Spectra were normalized for absorption at 
280 nm.






Maxima (nm) Minima (nm) Shoulders
R-2fIPP 354 322
Enzyme-bound S-2fIPP 354 323
cIPP 347 318






cIPP n.p. n.p. n.p.
R-2fIPP 315, 492 299, 394 251, 280, 352
6 N HCl S-2fIPP 315, 492 295, 393 260, 355
cIPP 315, 492 264, 391 356
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Figure 2.19. UV-vis absorption spectra of isolated FMN product in 8 M guanidine, 
pH 6. Lines represent R-2fIPP (dark green), S-2fIPP (purple).
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Figure 2.20. UV-vis absorption spectra of isolated FMN product in 6 N HCl. Lines 
represent R-2fIPP (dark green), S-2fIPP (purple) , and cIPP (yellow).
number of species that are observed spectroscopically and how their concentrations 
change with time. Spectra were truncated at 300 nm to simplify the analysis. When only 
three species were assumed in the oxidation pathway, the time course obtained is shown 
in Figure 2.21.A and the corresponding spectra of the major species are shown in Figure 
2.21.B. While the optimized spectra correspond well to the eIPP-adduct, radical and 
oxidized flavin species, the time course revealed a bimodal concentration profile for the 
eIPP-adduct, where the adduct is converted to the radical intermediate, which then decays 
to FMNox and then back to the reduced adduct. However, oxidation of a reduced FMN 
species is considered to be essentially irreversible,131 and formation of a large population 
of FMNred in the presence of O2 is unlikely. Therefore, the bimodal model was rejected 
and a four species model was evaluated.
When four species were evaluated, the optimization still resulted in a bimodal 
appearance for the eIPP-adduct (Figure 2.22.A). The spectrum of the unknown species 
had an absorption maximum at 375 nm with a smaller peak at 450 nm (Figure 2.22.B). 
These peak positions corresponded well to the spectrum of FMNox, but had different 
intensities (Figure 1.25). To correct for the bimodal eIPP-adduct concentration, another 
MCR-ALS analysis was performed with the concentrations for the radical adduct and 
FMNox as they appear in Figure 2.22.A. For the eIPP-adduct, only the concentration 
values up to the appearance of the second peak were used, and the concentration after that 
point was fixed at zero. The unknown intermediate concentration was determined by 
subtracting the summation of all the flavin concentration values from the TFC. Next, 
these concentration values were fixed so only the spectra were optimized in a single 
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Figure 2.21. MCR-ALS results for the oxidation of the eIPP-FMN adduct with three 
species. A, Time course; B, Spectra of the species in the time course. Lines represent 
eIPP-FMN adduct (black), eIPP-FMN radical (blue), FMNox (gold).
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Figure 2.22. MCR-ALS results for the oxidation of the eIPP-FMN adduct with four 
species, optimized model. A, Time course; B, Spectra of the species in the time 
course. Lines represent eIPP-FMN adduct (black), eIPP-FMN radical (blue), FMNox 
(gold) and unknown intermediate (magenta).
species and spectra that all differ from one another (Figure 2.23).
While the time course was not completely optimized (restricted to a single 
iteration), the spectrum of the unknown intermediate had some characteristics of reported 
flavin species. The peak at ~ 450 nm had noticeably decreased from Figure 2.22.B, but 
the peak at 375 nm remained and a peak or shoulder at ~ 300 nm was more intense 
(Figure 2.23.B). N5-alkylated flavins with a 4a-OOH or 4a-OCH3 group have peak 
maxima at 374 and 363, respectively, along with another peak at ~ 310 nm (in 
methanol).132 A peroxy-adduct or pseudobase have been proposed as intermediates in the 
oxidation of N5-alkylated flavins.132 Since the spectrum was calculated and not directly 
observed, no conclusions will be drawn other than the species is an N5-eIPP-FMN adduct 
with a 4a-peroxy or hydroxyl group.
An attempt was made to model the calculated time course in Figure 2.23.A based 
on Table 2.2. Differential equations based on this scheme were used to estimate the rate 
of change in the concentration of the eIPP-adduct, radical adduct and FMNox. From these, 
the concentration of the unknown intermediate (5-RFlox+) could be calculated by 
subtracting the summation of the other three flavin species from the TFC. For this 
experiment, oxygen concentration was a variable to avoid any assumptions about the rate 
of oxygen diffusion. A stir bar mixed the solution in the cuvette and the introduction of 
oxygen was not monitored. The optimum parameter values are in Table 2.9, without error 
terms. The traces formed from these rate constants are shown in Figure 2.24, overlaid 
with the traces from the time course of  Figure 2.23.A.
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Figure 2.23. MCR-ALS results for the oxidation of the eIPP-FMN adduct with four 
species, model correcting for bimodal eIPP-FMN adduct trace. A, Time course; B, 
Spectra of the species in the time course. Lines represent eIPP-FMN adduct (black), 
eIPP-FMN radical (blue), FMNox (gold) and unknown intermediate (magenta).
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Table 2.9. Parameter estimates for the oxidation of the eIPP-FMN adduct according 
to Table 2.2.
Parameter Value (units)
£1 10 M-1 min-1
k2 5.2 x 104 M-1 min -1
£3 300 M-1 min -1
£4 4.5 x 10-2 M-1 min -1
[O2] 1.0 x 10-4 M
TFC 3.01 x 10-5 M
Time (min)
Figure 2.24. Overlaid time course for the oxidation of the eIPP-FMN adduct with 
four species. Solid lines are the genoud fit to the MCR-ALS time course of the 
oxidation of the eIPP-FMN adduct according to Table 2.2 with parameter values in 
Table 2.9. Dotted lines are traces from the MCR-ALS analysis (Figure 2.23.A). 
Lines represent eIPP-FMN adduct (black), eIPP-FMN radical (blue), FMNox (gold) 
and unknown intermediate (magenta).
Discussion
Previous studies indicated that the IPP analogues vIPP, oIPP, eIPP and fmIPP 
formed N5 adducts with flavin when incubated with IDI-2. In these experiments, FMN 
was reduced photochemically or with NADPH and samples were washed with buffer that 
was not O2-free.68 However, these flavin adducts were O2 sensitive and required 
anaerobic conditions for comprehensive study. In addition, the adducts that were isolated 
by denaturation of the enzyme in acidic conditions were previously measured in 5 % 
trifluoroacetic acid, pH 0.5. The pKa value for the N1-position of oxidized flavin is 0, 
while the pKa value for the N5-position is < 0.133 Thus, a lower pH was needed to 
protonate flavin.
Spectroscopic reevaluation of the adducts in strict anaerobic conditions 
determined adduct formation for vIPP, oIPP and fmIPP at the C4a-position, while the 
eIPP-adduct was at the N5-position. In agreement with these findings, crystal structures 
performed by Hemmi and co-workers found that the C4a-position resulted in a better fit 
to the electron density map for the vIPP- and oIPP-adducts.58
The fluorescence properties of the adducts indicate that at room temperature, 
isolated adducts have spectral properties that are misleading. When enzyme-bound, the 
properties are consistent with those reported in the literature and are likely a result of the 
enzyme environment that prevents movement of the isoalloxazine backbone of flavin. 
One improvement to the measurement of isolated adducts would be to observe them at 
low temperatures (77 K).
During catalysis, there is a proposed tertiary carbocationic intermediate at C3 of 
IPP. Based on crystal structures of the S. shibitae IDI-2, the carbocation is 3.1 A from the
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C4a-position of flavin.58 The positive charge is stabilized by a partial negatively charged 
carbon atom at the 4a-position in the flavin ring system. For some of the substrate 
analogues above, the C4a carbon acted as a nucleophile. vIPP is initially an alternative 
substrate where the C5 methylene abstracts a proton from FMN, which yields a 
delocalized carbocation that undergoes nucleophilic attack by the flavin C4a carbon to 
the vIPP C6 carbon (Figure 2.25.A).58 The oIPP-adduct forms by first protonation of the 
epoxide ring,67 followed by nucleophilic attack by the flavin C4a carbon which causes the 
oxiranyl ring to open (Figure 2.25.B).
These conclusions can be extended to inhibitors that formed adducts and do not 









Figure 2.25. Proposed mechanisms for the formation of a flavin adduct with: A, 
vIPP; and B, oIPP.
not occur because of the electron withdrawing fluorine. Direct nucleophilic attack of the 
flavin C4a carbon occurs at the fmIPP methylene carbon, which causes the double bond 
to shift to the C3-C5 bond with subsequent release of fluoride (Figure 2.26). Another 
possible mechanism is the direct attack of the flavin C4a to the fmIPP 5-methyl carbon 
with fluoride as the leaving group (Figure 2.26).
A different mechanism must take place for eIPP, which results in an N5-adduct. 
Based on studies performed by our group, the covalent adduct is formed by the S-eIPP 
enantiomer.134 As expected, UV-vis studies with this enantiomer results in an identical 
spectrum as the racemic eIPP.134 The proposed mechanism involves proton abstraction 
from the N5-position by the epoxide oxygen, which opens the ring and yields a tertiary 
carbocation (Figure 2.27). The compact active site positions the carbocation near N5, 
rather than near C4a, which is the normal position for IPP. The lone pair of electrons 
above N5, which are posed to abstract a proton from C2 of the substrate, instead act as a 
nucleophile and attack the carbocation to form a bond (Figure 2.27).
The formation of adducts between the FMN cofactor and substrate analogues of 
IDI-2 are direct evidence that FMN is involved in catalysis. With the different adducts
R
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Figure 2.26. Proposed mechanisms for the formation of a flavin adduct with fmIPP.
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Figure 2.27. Proposed mechanism for the formation of a flavin adduct with elPP.
that are formed, the electronic structure around the flavin N5-C4a bond can be 
distinguished. The evidence supports a C4a carbon with a partial negative charge that 
likely stabilizes a carbocationic intermediate during catalysis. The N5 nitrogen donates a 
proton to yield a carbocationic intermediate that is subsequently attacked by a 
nucleophile nearest the positive charge. Future experimentation would include 
exploration of flavin analogues similar to those discussed in Chapter 1 or isotopically 
labeled at the N5 and C4a positions. The reactions in Table 2.2 are an oversimplification 
of the true oxidation of a flavin adduct but support the statistical analysis. The chemistry 
involved in flavin adduct oxidations has been studied,126 but not comprehensively. 
Comparatively, the oxidation of reduced flavins/flavoproteins has been studied 
extensively and is a well-known seven step process.131
The equilibrium of the comproportionation reaction for an N5-adduct (Eq. 2.5) 
lies heavily towards radical formation.126 The calculated results agree with this 
observation since the rate of radical formation was fast compared to the other rates (Table
2.9). If a parameter was included to account for the disproportionation (the reverse 
reaction of Eq. 2.5), no significant improvement in the fit was observed. The rate of
oxygen reactivity toward the reduced and radical N5-adducts (£1 and £3) appeared to be 
significantly slower than that observed in the literature. 3,5-Dimethyl-dihydrolumiflavin 
and 1-carba-1-deaza-5-ethyl-dihydrolumiflavin reacted with oxygen at rates of 0.6 -  1.8 x 
1 0 3, 132 and 3.9 x 103 M-1 min-1, 135 respectively. When in the radical oxidation state, these 
same compounds reacted with oxygen at rates of 24 and 37.8 x 103 M-1 min -1, 
respectively. Note that the 3,5-dimethyl-dihydrolumiflavin radical is less reactive towards 
oxygen than the eIPP-adduct. The differences observed are likely a result of the method 
of oxygen addition. For the eIPP-adduct, oxygen was allowed to diffuse into solution, 
while for the lumiflavin adducts, anaerobic solutions that contained the adduct were 
added to aerobic solutions via syringe or a stopped-flow apparatus. Another difference 
may be the form of flavin that was studied. Lumiflavin lacks the ribityl phosphate group 
present in FMN. Decay rates of several minutes and hours were observed for the 
oxidation of N5-FMN adducts formed with lactate oxidase. 129
The original hypothesis was that the spectra collected for the oxidation of an 
eIPP-adduct could be deconvoluted and that estimates for the rates of oxidation could be 
calculated. The deconvolution was possible, but based on the rate results, there are 
inadequacies that require improvement. Future experiments would benefit from greater 
restriction over the introduction of oxygen; such restrictions would include monitoring 
the oxygen concentration, the introduction of oxygen into the cuvette (control of the 
stirring rate), and monitoring the amount of light being received by the sample. The lack 
of strict control limits the confidence in the rate values as general descriptors of oxidation 
rates for N5-flavin adducts.
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CHAPTER 3
MECHANISM-BASED INACTIVATION OF ISOPENTENYL 
DIPHOSPHATE:DIMETHYLALLYL DIPHOSPHATE 
ISOMERASE BY THE NATURAL SUBSTRATES 
ISOPENTENYL DIPHOSPHATE AND 
DIMETHYLALLYL DIPHOSPHATE
Introduction
Spectroscopic evidence indicated that when FMN is bound in Tt-IDI-2 and 
reduced, the cofactor is in the anionic state.63 Based on density functional theory (DFT) 
calculations, a delocalized HOMO is directly above C4a of the anionic reduced 
isoalloxazine flavin backbone.77 The discovery that catalytically active IDI-2 produces 
FMN adducts with inhibitors is an indication that the partially negative C4a carbon may 
help stabilize a tertiary carbocationic intermediate (Chapter 2).58
In this chapter, a description of the same experiments of Chapter 2 is presented 
but with IPP and DMAPP, the natural substrates of IDI-2. After overnight incubations of 
the substrates with IDI-2, a substantial change was seen in the UV-vis absorption 
spectrum. Based on characteristics in UV-vis spectra, the position of the adduct was 
determined to be at the C4a-carbon of flavin. Mass spectrometry revealed that two 
different adducts formed. However, these adducts were formed after long-term 
incubations (overnight for one type and more than 3 weeks for the second type). While
the reaction may not be biologically relevant, the one isoprene unit adduct was observed 
in all mass spectra, including controls and those previously collected by our group.
Experimental Procedures
Materials. IPP, DMAPP, GPP and FPP were available from previous 
experiments. 13C5-IPP was provided by Dr. Aquiles E. Leyes. Powdered TiO2, ZrO2, 
Nb2O5 and graphite were from SkySpring Nanomaterials, Inc. Guanidine was from 
usb/Affymetrix. NADPH was from rpi. Other chemicals were from Sigma-Aldrich.
IDI-2 adduct preparation, isolation and UV-vis spectroscopic analysis. His- 
tagged Tt-IDI-2 was expressed and purified as previously described (Chapter 2).58 Adduct 
preparation assays and analyses were performed as previously described,58 with the 
following modifications (similar to Chapter 2). All assays were performed in an 
anaerobic chamber (O2 < 5 ppm) with solutions degassed by cycling argon purging with 
gas evacuation and allowed to equilibrate in the chamber for a minimum of 7 d. Enzyme 
and substrate were transferred to the anaerobic chamber the day of reaction. Assay 
solutions were 100 |iM FMN*IDI-2 and 800 |iM substrate, in 200 mM HEPES, pH 7.0 
containing 2 mM MgCh and 8 mM Na2S2O4, and were incubated overnight up to 7 d at 
37 °C. Isolation of the adduct was performed in the following ways: 1) Denaturation of 
the enzyme in 3.6 M guanidine/2 M KBr (denaturation buffer) followed by filtration 
through a 30kD MWCO ultrafiltration device (Amicon) or 2) His-tagged IDI-2 was 
applied to a Ni-IDA column (Affymetrix) and washed with denaturation buffer. 
Denaturation was also performed using 6 N HCl. Freshly prepared 6 N HCl was critical. 
Otherwise the sample would degrade before a spectrum could be measured.
Sample preparation for ESI-MS analysis. Initially, the same mass spectrometry
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method was used as for previous adduct studies.68 However, for a pure spectrum of the 
adduct, IDI-2 was washed 5 times with 50 mM ammonium acetate and then washed with 
denaturation buffer and filtered through a 30kD MWCO ultrafiltration device (Amicon). 
Excess metal oxide (TiO2, ZrO2 or Nb2O5) was added to the flow through that contained 
the FMN-adduct and the sample was vortex shaken for 30 min. The metal oxide was spun 
down at 15,000 g  and the supernatant removed. Impurities were removed with three 
cycles of washing the metal oxide with 10 mM Bis-Tris, pH 6.0 containing 150 mM 
NaCl (Bis-Tris buffered saline, or Bis-TBS), vortexing to resuspend the powder then 
centrifuging at 4000 g  to remove the supernatant. To elute the adduct, 200 mM sodium 
phosphate, pH 6.0 was added and the sample was vortex shaken for 5 min. The metal 
oxide was separated by centrifugation at 15,000 g, and the supernatant that contained the 
adduct was removed. As an additional enrichment step, the solution was applied to 
graphite powder, washed three times with 50 mM ammonium acetate and the adduct 
eluted with 50 mM ammonium acetate in 30 % acetonitrile. In a different enrichment 
procedure, the metal oxide step was skipped, and the deflavination solution was directly 
applied to graphite and eluted as above.
Samples subjected to TOF ESI-MS (Waters LCT Premier XE) were analyzed 
with the following parameters, in negative ion mode: capillary 2.5 kV, cone 55 -  100 V, 
scanned from m/z 50 -  1000 and for positive ion mode: 3.5 kV, 150 V and m/z 400 -  
2000, respectively. Samples from graphite purification were analyzed in negative ion 
mode, with parameters: capillary 2.5 -  2.8 kV, cone 10 V, scanned from m/z 50 -  1100.
Samples were also subjected to UPLC (Waters Aquity with PDA detector) under 
the conditions: negative ion capillary 2 kV, cone 30.0 -  35 V, extractor 3 -  4.6 V. Mobile
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phase A: 50 mM ammonium acetate, pH 7.0; B: Acetonitrile. Gradient conditions in % A 
(time elapsed in min): 99 (0), 99 (1), 0 (5), 0 (6), 99 (8). Flow rate 0.5 mL/min. 10 |iL 
injection volume. Column: Waters Aquity UPLC BEH Phenyl 1.7 |im. Diode array 
collection from 200 -  460 nm, scanned from m/z 100 -  1000.
Kinetics o f adduct formation. Inactivation experiments were performed in an 
anaerobic chamber with solutions pre-equilibrated for a minimum of 7 d in the chamber. 
Enzyme (500 nM) was incubated with IPP (0 and 0.28 -  97 mM) at 37 °C up to 7 d in 
200 mM HEPES, pH 7.0 containing 2 mM MgCh and 40 |iM dithionite. Aliquots were 
removed at set time points and assayed using the acid lability assay,63 with 50 |iM 14C- 
IPP in 200 mM HEPES, pH 7.0 containing 2 mM MgCh, 2 mM NADPH and 40 |iM 
FMN. Activity was determined for all samples and then added to the activity lost at each 
time point because of enzyme degradation (the 0 mM IPP sample). First order rate 
constants were determined for each [IPP]; these observed rates were then plotted against 
[IPP] and fit to the Michaelis-Menten equation to calculate kinact and Ki.
Isoprene production. Assays were prepared as for the UV-vis adduct assays 
described above, except were reduced with NADPH and were performed without 
anaerobic conditions. Reagents were mixed in headspace GC vials and were sealed with 
an air-proof screw-top cap. Incubations were performed for various times (each time 
point used a separate vial), and reactions were terminated by placing the vial on ice. 
Conditions varied both substrate (IPP or DMAPP) and presence or absence of the 
reductant. Headspace GC-MS analysis was performed at Danisco US Inc. (a division of 




UV-vis spectroscopic analysis. Control spectra were collected with enzyme 
reduced in an anaerobic chamber, then washed 5 times with 25 mM NH4CO3 to remove 
reductant. A spectrum was collected of FMNred*IDI-2 without IPP and immediately after 
addition of IPP (Figure 3.1). The adduct was observed when reduced enzyme was 
incubated with IPP for 24 h in an anaerobic chamber. The enzyme was washed to remove 
excess and unbound IPP and both the adduct bound IDI-2 and the control FMNred*IDI-2 
(without IPP) were measured. A peak shift from 353 nm for FMNred*IDI-2 to 344 nm for 
FMNred*IDI-2 with IPP indicated that a change in the flavin cofactor occurred during the 
incubation (Figure 3.1).
The cofactor was isolated with a deflavination solution (3.6 M guanidine/2 M
Figure 3.1. UV-vis absorption plots of FMN^IDI-2 after reduction. Prior to 
measurement, samples were washed 5 times with 25 mM NH4CO3, pH 7.8, to 
remove reductant. Lines represent: No substrate (blue); Addition of IPP after 
washing with NH4CO3 (magenta); 24 incubation without substrate (red); and 24 
incubation with IPP (green). Spectra normalized at 280 nm.
KBr) or 6 N HCl. A study evaluated the type of reductant (dithionite or NADPH) and the 
change in absorption over time (0.5, 4, 24 and 72 h). The guanidine isolated adduct 
appeared to be well formed after 24 h for either reductant (Figure 3.2.A and .C). 
However, isolation with 6 N HCl revealed the gradual appearance over time of a peak at 
400 nm. This peak corresponds to a C4a-adduct (Table 2.4) and indicates the adduct was 
not fully formed until about 72 h (Figure 3.3.A and .C). For both reductants and adduct 
isolation methods, if no substrate was added, there were no significant changes in 
absorption (Figure 3.2.B and .D and Figure 3.3.B and .D). The characteristics for the 
spectra collected at 72 h are reported in Table 3.1.
Oxidation of all three forms of the modified cofactor (enzyme-bound, guanidine 
freed and HCl freed) was studied when sample was exposed to O2 and light. The enzyme- 
bound adduct oxidized to a stable neutral radical intermediate, characteristic of the broad 
absorption peak around 600 nm with an isosbestic point at 485 nm (Figure 3.4). 
Oxidation continued to fully oxidized flavin with a maximum at 450 nm. However, the 
final product absorption was extremely weak and may have represented a population of 
FMN*IDI-2 that was not completely oxidized but existed in some other unidentifiable 
state.
No radical intermediate was detected for guanidine isolated adduct since there 
was no absorption change at 600 nm (Figure 3.5). However, there is a change with 
isosbestic points at 322 and 424 nm during the first 11 min. Afterwards, there appears to 
be a collection of different states without any distinct isosbestic points. The initial change 
is likely the oxidation of the adduct which leads to photodegradation at 11 min.
For the 6 N HCl isolated adduct, oxidation begins with a small peak at 400 nm
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Figure 3.2. UV-vis absorption plots of isolated FMN from IDI-2 at pH 6.0 under the 
following conditions. A, IPP + dithionite; B, Dithionite only; C, IPP + NADPH; D, 































Figure 3.3. UV-vis absorption plots of isolated FMN from IDI-2 in 6 N HCl under 
the following conditions. A, IPP + dithionite; B, Dithionite only; C, IPP + NADPH; 
D, NADPH only. Lines represent 0.5 (orange), 4 (green), 24 (purple) and 72 (red) h.
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Table 3.1. Absorption characteristics for deflavinated FMN under the following 
conditions.
Flavin Isolation Assay
Method Condition Maxima (nm) Minima (nm) Shoulders (nm)
Dithionite




Dithionite 220, 278, 374 256, 332 304
KBr, pH 6
NADPH 254 233 296
IPP + 
NADPH 220, 276, 375 252, 332 304
Dithionite
Only 314, 492 299, 399 262, 279, 357
6 N HCl
IPP + 
Dithionite 272, 398 257, 278 304, 356, 460
NADPH 259, 312, 493 243, 288, 394 356
IPP + 268, 308, 399, 249, 295, 377, 356NADPH 489 445
that results in a sharp, large (absorbance >> 2) peak at 400 nm with a noticeably bright 
yellow color (Figure 3.6). This transition occurs in two steps: the first gives spectra with 
isosbestic points at 287 and 329 nm and a spectrum with a peak at 500 nm. In the second 
step, the transition gives spectra with isosbestic points at 290, 354, and 447 nm and a 
final spectrum of protonated oxidized flavin.
The UV-vis absorption profile of FMNred*IDI-2 was further examined 
immediately and after a long (21 d) incubation of substrate (IPP, DMAPP, GPP and 
FPP). Control spectra were collected immediately after addition of substrate. 
IPP*FMNred*IDI-2 and DMAPP*FMNred*IDI-2 have identical spectra with a peak 
maximum at 430 nm and a shoulder at 316 nm, which differ from FMNred*IDI-2 that has
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Figure 3.4. UV-vis absorption plots of FMNadduct^IDI-2 oxidation. Time represents 
the time of exposure to both oxygen and light.
Figure 3.5. UV-vis absorption plots of oxidation of FMNadduct isolated using 3.6 M 
guanidine/2 M KBr, pH 6. Time represents the time of exposure to oxygen and light.
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Figure 3.6. UV-vis absorption plots of oxidation of FMNadduct isolated using 6 HCl. 
Time represents the time of exposure to both oxygen and light.
a maximum at 352 nm (Figure 3.7). The absorption spectrum for GPP with FMNred*IDI-2 
has a maximum at 348 nm, similar to FMNred*IDI-2. The solution with FPP was turbid 
and the absorption spectrum was void of any characteristics, perhaps because of FPP 
micelle formation at the high concentration needed for the adduct assays. After a 24 h 
incubation, the IPP*FMNred*IDI-2 spectrum had a peak shift to 344 nm, while both 
FMNred*IDI-2 and GPP with FMNred*IDI-2 were void of a peak shift with a maximum at 
~ 350 nm (Figure 3.8).
ESI-MS analysis. For mass spectrometry, the adduct isolated with denaturation 
buffer was enriched using a phosphoproteomics procedure.136,137 Each metal oxide (TiO2, 
ZrO2 and Nb2O5) appears vibrant white in color. When FMN was added, the 
disappearance of yellow color in solution with subsequent yellowing of the metal oxide 
provided qualitative evidence of adsorption. FMN was not observed to desorb during
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Figure 3.7. UV-vis absorption plots of FMNred^IDI-2. Lines represent immediate 




Figure 3.8. UV-vis absorption plots of FMNred^IDI-2 after 24 h incubation. Lines 
represent nothing (orange), IPP (green), GPP (blue), and FPP (red).
washes. While elution is typically performed under basic conditions,138 elution can be 
performed near neutral pH by including NaCl in a sodium phosphate buffer.139 Elution 
with Bis-TBS, pH 6.0 resulted in ~ 60 % recovery of FMN from TiO2 and ZrO2, but only 
8 % recovery from Nb2O5. Attempts to adsorb and elute IPP were unsuccessful, perhaps 
because of the bidentate binding of phosphate to metal oxides.140
To eliminate phosphate from the metal oxide elution, a second enrichment on 
graphite was performed.141 Successfully used to enrich phosphoproteins for mass 
spectrometry,142 and for separation of nucleosides and their corresponding phosphates,143 
the technique was modified and applied to enrich FMN. Following the metal oxide 
enrichment step, the graphite step resulted in a total recovery of 13.4%. When the 
graphite step was performed without metal oxide enrichment, recovery was 13.5%. Either 
the metal oxide or graphite procedures produced similar MS results (Figure 3.9).
Six different incubations with IDI-2 were performed: no substrate (control), IPP, 
13C5-IPP, DMAPP, GPP and FPP. Each spectrum contained peaks at m/z 255.2 and 455.1, 
which represent lumiflavin and fully oxidized FMN, respectively. The expected neutral 
mass of an IPP-FMN adduct would be 702.1 or 704.1 (Figure 3.10). However, no peak 
was observed that corresponded to either mass. Instead, a peak at m/z 525.2 was 
consistently observed for incubations of IPP and DMAPP with IDI-2 for different lengths 
of time (Figure 3.11.A and .B). The mass increase from m/z 455.1 to 525.2 corresponded 
to a single isoprene unit increase (Figure 3.10). To verify that isoprene was the source of 
this increase, IDI-2 was incubated with 13C5-IPP. As expected, a 5-unit peak shift to m/z
530.2 was observed, which supports an isoprene-FMN adduct (Figure 3.11.D). 
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Figure 3.9. Negative ion TOF ESI mass spectrum of purified FMN from 7if-IDI-2 
after a 21 d incubation. A, No Substrate (graphite purified); B, IPP (graphite 
purified); C, No Substrate (ZrO 2 purified); D, IPP (ZrO2 purified). Note: Full 
spectra available in Appendix B.
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Figure 3.10. Chemical structures and neutral masses of possible FMN adducts with 
IPP and isoprene. Based on UV-vis spectral evidence, only adducts at the C4a- 
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Figure 3.11. Negative ion TOF ESI mass spectrum of isolated FMN after a 24 h 
incubation of 7MDI-2 with different substrates. A, No Substrate; B, IPP; C, 
DMAPP; D, 13C5-IPP. Note: Full spectra available in Appendix B.
incubated with IDI-2 and the 13C5-IPP incubation (Figure 3.11.A and .D). This peak 
likely corresponds to adduct formation in vivo.
Another investigation involved a longer incubation of 27 d. When IPP was 
incubated for several weeks, a new peak appeared at m/z 593.2 (Figure 3.12.A) and 
corresponded to the addition of a second isoprene unit to the isoprene-FMN adduct 
(Figure 3.13). To investigate whether IDI-2 was involved with chain elongation and 
formation of a C10 prenyl unit adduct, IDI-2 was incubated with GPP or FPP. However, 
no adduct formation was observed (Figure 3.12.B and .C).
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Figure 3.12. Negative ion TOF ESI mass spectrum of isolated FMN after a 27 d 
incubation of Tt-IDI-2 with different substrates. A, IPP; B, GPP; C, FPP. Note: Full 
spectra available in Appendix B.
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Chemical Formula: C 2 7H 39 N 4 O 9 P  
Exact Mass: 594.25
Chemical Formula: C2 7 H3 9 N4 O9 P 
Exact Mass: 594.25
Figure 3.13. Chemical structures and neutral masses of possible FMN diprenylated 
adducts.
UPLC-MS analysis. The same samples studied with negative ion TOF ESI-MS 
were also studied with UPLC. Four different flavin species were detected and could be 
separated in an 8 min run. Figure 3.14 highlights the normalized chromatograms of the 
four different masses and their retention times. Figure 3.15 shows the corresponding mass 
spectra for the chromatograms in Figure 3.14. Lumiflavin (m/z 255.1), a light degradation 
product of FMN, was found in every sample and eluted around 4.0 min. In the 
chromatograms, fully oxidized FMN (m/z 455.1) was the first species to elute around 2.4 
min and the isoprene-FMN adduct (m/z 525.2) eluted at 2.8 min. The diprenylated adduct 
species (m/z 593.2) eluted at 3.1 min. Fully oxidized riboflavin (m/z 374.1) was not 
detected. As hydrophobicity increased, the retention time increased as expected using a 
phenyl column with reverse phase conditions. This indicates that the suspected 
diprenylated adduct is more hydrophobic than the FMN-isoprene adduct.
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Figure 3.14. UPLC-MS chromatogram highlighting masses (minus H) of different 
flavin species. Lines are m/z 255.2 (lumiflavin, red), 455.1 (FMN, green), 525.2 
(isoprene-FMN adduct, cyan), and 593.2 (diprenyl-FMN adduct, blue).
Kinetics o f adduct formation. Data fit to a first over exponential equation started 
at 90 min through 60 h. Earlier data did not improve the fit and data collected after 60 h 
maintained the same level of activity as earlier time points. The best fit, first order 
exponential curves are shown in Figure 3.16.
The observed rate of decay was plotted against IPP concentration to determine the 
rate of inactivation (Figure 3.17). The parameters for the best-fit line are in Table 3.2. 
The rate of inactivation is extremely slow, a probable reason why the adduct was not 
detected earlier.
Isoprene production. Calibrated peak area was used to determine the molarity of 
isoprene collected from 1.8 mL of vial headspace. Without enzyme, the rate of DMAPP 
degradation into isoprene was faster over 90 min than when IDI-2 was incubated with 
IPP or DMAPP (Figure 3.18). However, in the first few time points, isoprene was 
produced more readily with IDI-2 and DMAPP than the other conditions. In these first
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Figure 3.15. Negative ion ESI mass spectra corresponding to the UPLC 
chromatograms in Figure 3.14. A, Lumiflavin; B, FMN; C, isoprene-FMN adduct; 
D, Potential diprenylated FMN adduct.
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Figure 3.16. Best fit curves of the activity of IDI-2 after incubation with IPP. 
Adjusted activity corrects for enzyme activity loss over time.
Figure 3.17. Observed rates plotted against IPP concentration.
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Table 3.2. Kinetic parameters of the inactivation of IDI-2 by IPP.
Mean S.E. 95% C.I.
kinact (min-1) 2.12 x 10-3 6 x 10-5 (1.99 x 10-3, 2.25 x 10-3)
Ki (^M) 0.264 0.036 (0.188, 0.352)
few time points an estimate of the rate of isoprene synthase activity was determined to be 
2.1 x 10-4 nmol isoprene/(min*mg). In Figure 3.18.B, the standardized residuals of the 
best fit lines have curvature. For samples with enzyme, the curvature indicates a better fit 
would be hyperbolic, so the rate of isoprene production is plateauing. Meanwhile, the 
curvature of the DMAPP without IDI-2 residuals indicates that an exponential fit would 
be a better fit and the rate is exponentially increasing.
For a longer incubation, the most obvious result is that DMAPP without enzyme 
produces more isoprene than when IDI-2 was included (Figure 3.19). Without enzyme, 
the fastest rate of isoprene production from DMAPP occurred when NADPH was 
included in the assay. When IDI-2 was incubated with IPP and NADPH, there was a 
steady rate of isoprene production, which is reasonable considering that the enzyme is 
catalytically active and producing DMAPP. Some other conditions that were not included 
in the figure did not produce any detectable isoprene. These conditions include only assay 
solution (no IDI-2 and no substrates) and IDI-2 with or without NADPH (no substrates). 
After 42 h there was a small amount of isoprene production from an incubation of IPP 
(no IDI-2), with or without NADPH (43 or 50 nM, respectively).
Discussion
The discovery of flavoenzymes involved in the well-studied isoprenoid pathway 
introduced a new area of chemistry for flavoenzymes. Recent evidence implies the N5-
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Figure 3.18. Best fit linear lines of isoprene production with NADPH in a short 
incubation. Lines represent IDI-2 and DMAPP (green), IDI-2 and IPP (blue) and 
only DMAPP (magenta). A, Isoprene production versus time; B, Standardized 
residuals of the best fit lines in A.
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Figure 3.19. Best fit linear lines of isoprene production with NADPH in a long 
incubation. Lines represent IDI-2 and DMAPP (red), IDI-2 and IPP (green), 
DMAPP with no enzyme (orange) and DMAPP with no enzyme or NADPH (blue).
position of flavin participates in both proton donation and abstraction during the 
isomerization of IPP to DMAPP.62,76 Also, crystal structures and spectroscopic 
observations indicate that the C4a flavin position covalently bonds to substrate 
analogues.58 Together, these indicate that flavin is actively participating in catalysis.
In crystal structures of IDI-2 with IPP, the C3-position of IPP is poised directly 
above the C4a-position of flavin.58,73 Calculations have shown that the C4a-position of 
flavin has a delocalized HOMO when in the anionic reduced state.77 Thus, during 
carbocation formation of IPP, there could be complex formation between the substrate 
and cofactor. During an overnight incubation with IPP and IDI-2, an FMN-adduct was 
observed. There is a bathochromic shift (375 -> 399 nm) when the adduct is guanidine 
denatured at neutral pH compared to the protonated adduct in 6 N HCl. Oxidation of the 
free adduct in either solution required both oxygen and light and results in direct oxidized
FMN without any intermediates. These results are characteristic of an adduct at the C4a- 
position (Table 2.4). Interestingly, when enzyme-bound, the adduct proceeds through a 
radical intermediate, a characteristic of an N5-adduct. A radical was observed for Tt-IDI- 
2 when IPP was incubated with the enzyme prior to reduction.63 In this case, the radical 
was evidence only that Tt-IDI-2 was capable of stabilizing the neutral radical 
intermediate and not evidence of a radical intermediate in catalysis. Likewise, one would 
speculate that the FMN adduct observed was oxidized to a radical flavin that could be 
stabilized by the enzyme, and not that the radical is a critical intermediate.
A peak increase from m/z 455.1 of oxidized FMN to m/z 525.2 for the FMN- 
adduct confirmed that only a single isoprene unit was added to FMN. However, the 
diphosphate group was retained when adducts formed between FMN and substrate 
analogues of IDI-2.68 The expected neutral mass of an adduct with FMN and IPP of 702 
or 704 (depending on which IPP carbon adduct formation was occurring) was not 
observed in any experiments. Thus, the diphosphate group is likely a leaving group 
during adduct formation. The mass increase was also observed with DMAPP as the 
substrate. When 13C5-IPP was the substrate, the mass increased an additional 5 units, as 
would be expected if the source of the adduct was the carbon backbone of IPP. With 
UPLC-MS, FMN was separated from the isoprene-adduct.
In both the control, where no substrate was incubated with IPP, and incubation 
with 13C5-IPP, there was a peak at m/z 525.2. The source of this mass was expected to be 
from the IPP pool of E. coli, the expression organism; however this hypothesis was not 
evaluated any further.
When incubation time was increased to several weeks, rather than just a few days,
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a new peak at m/z 593.2 was observed. Initially thought to be contamination, the mass 
corresponds to a two-isoprene unit adduct with FMN. LC-MS separated the two-isoprene 
unit adduct from both FMN and the one-isoprene unit adduct. The fragmentation pattern 
of the 593.2 mass had the characteristic pattern for FMN, with a major peak at m/z 371 
(corresponds to the ribityl group, benzyl and piperazinyl rings, Figure 3.20). The m/z
593.2 FMN mass was either caused by chain elongation or diprenylation. In order to 
determine which was true, ion source fragmentation of the cofactor adduct was 
explored.144 However results were inconclusive.
One concern with the observation of adduct formation in the presence of 
dithionite is the possibility of sulfoxide, sulfite or dithionite adduct formation with the 
isoalloxazine ring system of FMN.145,146 However, when NADPH was used as a 
reductant, absent dithionite, adduct formation still occurred. In addition, 13C5-IPP 
increased the mass of the adduct by 5 mass units. The several-week-long incubation that 
resulted in a new mass could be the result of the equilibrium between dithionite and two 
sulfoxylate radical ions.147 Numerous sulfoxide, sulfite and dithionite adducts can be 
hypothesized (Figure 3.21) and their masses can be searched for in the measured mass
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Figure 3.21. Possible adducts between FMN and isoprene-FMN adducts with 
sulfoxide, sulfite and dithionite with their neutral masses.
spectra. Importantly, none of the masses in Figure 3.21 correspond to peaks at m/z 526.2 
or 594.2, further evidence that the observed adduct was not derived from dithionite.
The rate of inactivation was studied to quantify this slow process. Interestingly, 
the enzyme always retained some activity (Figure 3.16). Based on the spectroscopic 
evidence (Figure 3.2 and Figure 3.3), there appeared to be complete enzyme inactivation 
when [IPP] > [IDI-2]. In the inactivation studies, as [IPP] increased, [IPP] >> [IDI-2]; 
however there was still activity perhaps a result of DMAPP hydrolysis because of the 
lengthy incubation times. Any isoprene (bp = 34 °C) would not stay in solution at 37 °C, 
therefore equilibrium with the enzyme is unlikely. Furthermore, the DMAPP hydrolysis 
product, 3-methyl-2-buten-1-ol, would lack the diphosphate group, a necessity for 
substrate binding in IDI-2. Thus, these products would be unavailable for catalysis and 
enzyme was still available to catalyze the radioactive substrate when tested for activity. 
While the IDI-2 manufactured adduct may be biologically irrelevant, prenylated flavins 
have been identified from two different sources.
The first identified example of a prenylated flavin was from visible light 
irradiated riboflavin in the presence of isohumulones in a N2-flushed environment.148 
Humulones are prenylated phloroglucinol natural products from the hop plant and are 
isomerized to isohumulones during the process of brewing beer (Chapter 1).28 When beer 
is exposed to light, riboflavin in the triplet excited state transfers an electron to 
isohumulone, which then undergoes a bond cleavage resulting in a 3-methyl-2-butenyl 
radical. This radical reacts with a thiol group to form 3-methyl-2-butene-1-thiol, the 
compound responsible for 'skunky' beer.149 In the decreased O2 environment, 
recombination between the flavin semiquinone radical and the 3-methyl-2-butenyl radical
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results in the prenylated flavin at both the C4a- and N5-positions.
The other example is not believed to be a direct prenylation of riboflavin, but 
rather of a riboflavin degradation product. The prenylation occurs at the N5-position and 
then undergoes a cyclization with the benzyl side of what remains of the isoalloxazine 
backbone to yield hunanamycin A.150 The compound was isolated from a Bacillus strain 
and mimics synthetic riboflavin synthase inhibitors, but did not show significant 
antimicrobial activity.
The biological relevance of adduct formation by IDI-2 seems to be one of 
irrelevance and serendipity. One explanation for adduct formation would be that IDI-2 
produces isoprene. However the low isoprene synthase activity excludes this possibility. 
Another explanation would involve a feedback mechanism, but the slow rate of adduct 
formation restricts in vivo observation of the adduct to an instance of induced 
recombinant protein expression. Recombinantly expressed enzymes can be catalytically 
active in the cell, particularly in the case of an enzyme in the early isoprenoid pathway 
because IPP and DMAPP are ubiquitous in the cell. The high number of expressed 
enzyme increases the chance that this adduct would be observed. The sluggish nature of 
IDI-1 may exist in IDI-2, causing isomerization to fluctuate prior to product release.151 If 
this were the case, adduct formation may be a result of a rare catalytic mistake.
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CHAPTER 4
KINETIC MECHANISM OF Streptococcus pneumoniae TYPE 2 
ISOPENTENYL DIPHO SPHATE:DIMETHYLALLYL 
DIPHOSPHATE ISOMERASE
Introduction
The first published phylogenetic relationships of organisms with a gene for IDI-2 
located the gene in the Bacteria and Archaea domains of life.45 IDI-2 has been cultured 
and studied from the species, Bacillus subtillus,45 Streptomyces sp. strain CL190,57 
Thermus thermophilus,63 Staphylococcus aureus,64 and Sulfolobus shibatae.152 While the 
extremophilic organisms T. thermophilus and S. shibatae have proved to be useful 
enzymes to study the chemical intricacies of IDI-2, they fail to model IDI-2 as a potential 
drug target.
With the advent of genomic technologies, enzymes that are essential and unique 
to human pathogens could be investigated as potential antibacterial drug targets. The 
isoprenoid biosynthetic pathway has been targeted since humans use the mevalonate 
(MVA) pathway and IDI-1 to produce isoprenoids, while several pathogens utilize the 
methylerythritol phosphate (MEP) pathway and/or IDI-2.153 For example, fosmidomycin 
inhibits two enzymes in the MEP pathway and has been used successfully as an antibiotic 
against E. coli and Plasmodium falciparum (malaria parasite).154 Streptococcus 
pneumoniae produces isoprenoids via the MVA pathway with IDI-2.153 A currently
studied drug target in the MVA pathway of S. pneumoniae is the mevalonate kinase 
enzyme. The enzyme is inhibited at an allosteric site by diphosphomevalonate, whereas 
the human mevalonate kinase is unaffected.155 From this study, mevalonate analogues 
were studied and the authors found characteristics in the analogues that were preferred by 
mevalonate kinase.156
IDI-2 from S. pneumoniae has not yet been explored as a drug target. Presented 
here are the kinetic characteristics of S. pneumoniae, which are the initial steps towards a 
better understanding of the enzyme and its viability as a drug target.
Experimental Procedures
Materials. HEPES, HEPES sodium salt and NADH were purchased from rpi. 
Magnesium chloride hexahydrate, molecular biology grade and FMN (97% pure) were 
purchased from Sigma-Aldrich. 14C-IPP (60 |iCi/^mol) was purchased from Perkin- 
Elmer. NIPP (#,#-dimethyl-2-amino-1-ethyl diphosphate) was available from earlier 
experimentation.63 5-Deaza-FMN was provided by Dr. Seoung Choi.
Expression and purification. E. coli M15 cells with plasmid coding for 
Streptococcus pneumoniae IDI-2 (Sp-IDI-2) were expressed and purified as previously 
described for the T. thermophilus IDI-2,58 with the following modifications. Frozen cells 
were thawed with binding buffer (20 mM sodium phosphate, pH 7.4, with 20 mM 
imidazole and 500 mM NaCl), lysed with sonication and centrifuged. The lysate 
supernatant was applied to a HisTrap FF Crude Ni2+ affinity column (GE Healthcare). 
Purification was performed at 4 °C with a step gradient of binding buffer that contained 
increasing imidazole (20, 40, 500 mM). After the protein was loaded onto the affinity 
column, the enzyme was deflavinated with a wash of 2 M KBr in binding buffer. Enzyme
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concentration was determined using the BCA assay (Pierce).
Kinetic assays. The acid-lability assay, with modifications described previously, 
was used to determine kinetic parameters.63 Briefly, assay buffer was equilibrated at 37 
°C and the reaction initiated with the addition of Sp-IDI-2 diluted in 0.14 mg/mL BSA in 
10 mM HEPES, pH 7.0. After 10 min, the reaction was quenched with 200 |iL 
MeOH:HCl (4:1) and incubated for another 10 min. Samples were removed and 1 mL 
ligroin added and vigorously vortexed, allowed to separate for 10 min, then 500 |iL of the 
organic layer was added to scintillation fluid (UltimaGold, Perkin-Elmer). The assay 
sample disintegrations per minute (DPM) were counted, along with total count and blank 
samples (TriCarb 2910TR, Perkin-Elmer). Blank samples were performed as described 
above, but instead of enzyme, reactions were initiated with H2O. Total count samples 
were the same volume of assay buffer, without enzyme, used in the reaction added 
directly to scintillation fluid. The assay sample order for each replicate was randomly 
assigned. FMN, 5-deaza-FMN and NADPH or NADH stock solutions were prepared the 
day of experimentation. FMN and 5-deaza-FMN stock concentrations were determined 
with UV-vis spectroscopy and the extinction coefficients of 12,200 M-1 cm-1 at X450,115 
and 12,000 M-1 cm-1 at X396,157 respectively.
Single substrate saturation assays. Single substrate experiments were replicated 
three times. The general assay conditions were 60 nM apo-Sp-IDI-2 in 200 mM HEPES 
(pH 7.0 at 37 °C) containing 2 mM MgCh, 2 mM NADPH and 0.14 mg/mL BSA in 10 
mM HEPES (pH 7.0). For variable FMN (constant IPP), the conditions included 150 |iM 
IPP (spiked with [14C]-IPP) and 0.25 -  5.0 |iM FMN. For variable IPP (constant FMN), 
the conditions were 8 |iM FMN and 15 -  400 |iM IPP (spiked with [14C]-IPP).
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Bisubstrate assays. Bisubstrate kinetic experiments were replicated four times. 
Assays were prepared as a grid of varying IPP (5.0 -  200 |iM, spiked with [14C]-IPP) and 
FMN (0.51 -  4.1 |iM) concentrations in 100 mM HEPES (pH 7.0 at 37 °C) containing 
25 mM MgCl2, 10 mM NADH and 0.14 mg/mL BSA in 10 mM HEPES (pH 7.0) and 
were initiated with the addition of 7.5 nM apo-Sp-IDI-2.
Inhibition assays. Inhibition kinetic experiments were replicated three times, for 
each inhibition experiment. The general assay conditions were 100 mM HEPES (pH 7.0 
at 37 °C) containing 25 mM MgCh, 10 mM NADH and 0.14 mg/mL BSA in 10 mM 
HEPES (pH 7.0). Experiment specific conditions are listed below.
NIPP inhibition studies. For variable FMN, assay buffer contained 61.2 |iM IPP 
(spiked with [14C]-IPP) and a grid of FMN (0.93 -  2.6 |iM) and NIPP (0, 3.8 -  12.9 |iM). 
For variable IPP, assay buffer contained 1.5 |iM FMN and a grid of IPP (spiked with 
[14C]-IPP) (72 -  300 |iM) and NIPP (0, 6.7 -  52 |iM). 20 nM apo-Sp-IDI-2 was added for 
both conditions.
5-DeazaFMN inhibition studies. For variable FMN, 7.5 nM apo-Sp-IDI-2 was 
added to assay buffer with 23.3 |iM IPP (spiked with [14C]-IPP) and a grid of FMN (0.56 
-  3.5 |iM) and 5-deazaFMN (0, 0.02 -  0.16 |iM). For variable IPP, 15 nM apo-Sp-IDI-2 
was added to assay buffer with 1.6 |iM FMN and a grid of IPP (spiked with [14C]-IPP) 
(18 -  225 |iM) and 5-deazaFMN (0, 0.05 -  0.25 |iM).
Data analysis. Single substrate data were fit to the Michaelis-Menten equation 
with an additional term for substrate inhibition (Equation 4.1). Bisubstrate kinetic data 
were fit to the following: the standard sequential ordered and random equations (Eqs. 4.2 
and 4.3),158 a modified Multiple Essential Activator Site velocity equation (Eq. 4.4),158
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and a standard sequential ordered model with Hill coefficients (Eq. 4.5). Eqs. 4.6 
were used to fit the inhibition data. Analysis was performed using R version 3.0.0,11 
the packages nlstools,159 calibrate,160 and dichromat.121
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Overexpression and purification. The purification step for the Sp-IDI-2 was 
crucial to obtain partial holoenzyme or pure apoenzyme. Inconsistent results were
buffer. To avoid any ambiguity in the final form of the Sp-IDI-2 enzyme, a 2 M KBr 
wash step was introduced to completely deflavinate the enzyme and this was confirmed 
with UV-vis spectroscopy where no flavin peaks were observed at ~360 and 450 nm 
(data not shown). The residual activity of the apoenzyme, without added FMN, resulted 
in only 0.3% activity compared to fully active enzyme with FMN in the assay buffer.
Kinetic assays. For purposes of proper statistical analysis, all equations were 
modified according to the following procedure. To calculate velocity from raw data, it 
was necessary to first compute the ratio of sample DPM to the DPM from the total counts 
(product ratio). This ratio was multiplied by IPP concentration to yield the concentration 
of product, DMAPP. The concentration of product divided by time in seconds equals the 
velocity of the reaction (Eq. 4.10).
Substitution of equation 4.10 into the equations presented in the Experimental 
Procedures section allowed for each equation to be solved for in terms of the product 
ratio. Each analysis was performed on the substituted equations, but figures are presented 
with velocity, rather than ratio on the y-axis.
Residual analyses of the fitted equations indicated that the residuals were not 
randomly distributed. A logarithmic transformation of both the response and model
obtained by deflavination when Ni2+ bound His6-Sp-IDI-2 was only washed with binding
4.10
successfully randomized the residuals. Figure 4.1 shows an example of the residuals 
before and after transformation. The horn pattern in Figure 4.1.A indicates residual 
heteroscedasticity (meaning the residuals are heterogeneously distributed). The nearly 
homogeneous distribution of the residuals in Figure 4.1.B is indicative of a properly fit 
model with proper statistical assumptions. After transformation and an initial fit, if there 
were any standardized residuals with an absolute value greater than four, these were 
considered significant outliers and were removed so a new initial fit could be conducted. 
For the new initial fit (and any fit without significant outliers), any standardized residuals 
with an absolute value greater than two were removed and a final fit was performed. 
After the final fit, further diagnostics were performed for informational purposes only 
and no further modifications were made.
The choice of residual elimination was based on the standard normal curve for
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Figure 4.1. Standardized residual plots comparing data sets. A, Untransformed 
data; B, Transformed data. The data set and model are identical. However the right 
hand model has undergone a logarithmic transformation. The lines represent 
smoothing curves of the maximum and minimum points at each fitted value.
residuals (Figure 4.2). A standardized residual with an absolute value greater than 4 has a 
probability of occurrence less than 1 out of 10,000. With such a low likelihood, these 
values are true outliers. Standardized residuals with absolute values greater than 2 have a 
probability of less than 5 out of 100. These are considerably more likely values; however, 
their elimination is reasonable for smaller data sets and ultimately improves the overall 
error associated with parameter values.
Single substrate kinetics. Saturation of apo-Sp-IDI-2 with either IPP or FMN and 
variation of the other substrate gave Michaelis-Menten curves that taper at high substrate 
concentration (Figure 4.3). The data were fit to Eq. 4.1 to include substrate inhibition. 
The kinetic parameters are described in Table 4.1 and Table 4.2.
The kcat values are similar to those obtained for the T. thermophilus enzyme of
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Residual Values
Figure 4.2. Standard normal curve for standardized residuals with mean of 0 and 
standard deviation of 1. Lines represent probabilities (shown as percentages) of the 
standard normal curve. For example, data have a probability of 0.6827 of being 
found within one standard deviation of the mean.
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Figure 4.3. Single substrate kinetics plots for ^ -ID I-2 . A, Variable FMN, [IPP] = 
150 ^M; B, variable IPP, [FMN] = 8 ^M. Points are the average of three separate 
experiments and the line is the best fit line through the data.
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Table 4.1. Kinetic parameters for »Sp-IDI-2 with variable FMN (constant IPP).
Mean S.E. 95% C.I.
kcat (s 1) 0.196 0.011 (0.174, 0.223)
Kfmn (^M) 0.343 0.044 (0.259, 0.450)
Ki (^M) 6.40 1.01 (4.61, 9.17)
Table 4.2. Kinetic parameters for »Sp-IDI-2 with variable IPP (constant FMN).
Mean S.E. 95% C.I.
kcat (s 1) 0.141 0.009 (0.125, 0.161)
Kipp (^M) 40.0 4.1 (32.5, 49.7)
Ki (^M) 292 39 (221, 388)
0.13 and 0.18 s-1 for variable FMN and IPP, respectively.63 Likewise, the Km for variable 
IPP is similar to the S. aureus enzyme (17 |iM),64 but larger than the T. thermophilus 
enzyme (5.6 |iM).63 The Km for variable FMN differs from the T. thermophilus enzyme 
(4.7^M).63 There were no similar studies with other IDI-2 enzymes that indicated 
substrate inhibition, so a comparison could not be made for the Ki parameter.
Bisubstrate kinetics. The bisubstrate kinetics of Sp-IDI-2 were investigated to 
determine the Sp-IDI-2 mechanism. The assay conditions used for the single substrate 
kinetics were not suitable for the bisubstrate studies and required reoptimization.
Initial bisubstrate experiments exhibited substrate inhibition at high substrate 
concentrations. At lower substrate concentrations, reproducibility was an issue. To 
resolve these problems, the reductant and Mg2+ used in the assay were investigated. 
NADPH powder was stored at -20 °C in a desiccator for up to a year and 100 mM stock 
solutions were prepared with a 7 d expiry and stored at -20 °C. However, literature
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studies found that using optimized conditions (lyophilization from a solution of 200 mM 
NaCl in pH 9.0 Tris buffer), NADPH degradation at -20 °C was 20% over one week.161 
The half-life of NADPH in solution at 37 °C is only 71 min in pH 6.0 buffer (interpolated 
from rate constant determinations at 30 and 41 °C).162 While these conditions were 
suitable for the Jt-IDI-2 enzyme,63 Sp-IDI-2 was more sensitive to reductant. Steady state 
kinetic curves of NADPH and NADH gave similar results with hyperbolic curves (kcat = 
8.7 x 10-2 and 7.3 x 10-2 sec-1, respectively) (Figure 4.4). The dithionite reduced data 
required a sigmoidal fit yielding a kcat = 2.6 x 10-2 sec-1. Dithionite was not suitable and 
appeared to degrade within the span of the experiment, as the assay samples were visibly 
yellow when enzyme was added to initiate the reaction. Compared to the half-life of 
NADPH at 41 °C (55 min), NADH is considerably more stable (half-life of 400 min)
[IPP] (nM)
Figure 4.4. Steady state kinetics of ^ ^-IDI-2 with NADPH (green), NADH (red) and 
dithionite (black) as reductants. Each point represents the average of three data 
points. Both NADPH and NADH were fit to the Michaelis-Menten equation. The 
dithionite data were fit to a modified Michaelis-Menten equation that included a 
Hill coefficient and a baseline correction parameter.
(unfortunately data were not available to interpolate these results to 37 °C) . 162 Based on 
the greater stability of NADH, this was chosen as the reductant for the Sp-IDI-2 enzyme. 
Next, by comparing enzyme activity, the optimum concentration of NADH was 
determined as 10 mM (Figure 4.5). After optimization of the reductant, the dication 
concentration was investigated.
Formerly, stock solutions of 200 mM MgCh were prepared with an old supply of 
MgCl2*6H2O and several drops of 5 N HCl and gave a solution with pH ~ 1 -  2. Without 
any acid, a 1 M solution, pH ~ 5 -  6 , could be prepared with newly purchased 
MgCl2*6H2O. With the new material, optimum enzyme activity was achieved with 25 
mM MgCl2 (Figure 4.6). An interesting consequence of increasing Mg2+ concentration 
was that blank readings decreased (Figure 4.7).
With the optimized conditions, the activity of Sp-IDI-2 was studied as both a
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[NADH] (mM)
Figure 4.5. Dependence of ^ ^-IDI-2 activity on [NADH]. The curve represents the 
best fit through the data using the Richards equation and is for visualization 
purposes only. The dark triangle represents the original [NADPH].
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Figure 4.6. Dependence of ^ ^-IDI-2 activity on [Mg2+]. The curve represents the best 
fit through the data using a substrate inhibition curve and is for visualization 
purposes only. The dark triangle represents the original [Mg2+].
function of IPP concentration at different concentrations of FMN and as a function of 
FMN concentration at different concentrations of IPP. A ping-pong type mechanism was 
immediately excluded because the data in the reciprocal plots tend towards a common 
point of intersection, rather than parallel as in a ping-pong mechanism. The data and best 
fit lines to Eq. 4.2, a sequential mechanism with FMN binding first (evidence for this 
model will be elaborated in the inhibitor kinetic studies results) are shown in Figure 4.8.A 
and Figure 4.9.A. The residual plots for these best-fit lines are shown in Figure 4.8.B and 
Figure 4.9.B. In addition to the poor fits as shown in Figure 4.8.A and Figure 4.9.A, the 
parameters for the fit were kcat = 1.58 ± 0.18, Kipp = -42.3 ± 9.8, and Kfmn = -12.2 ± 2.5. In 
a previous study, negative values excluded the model that was fit and a different model 
was necessary to describe the data.163
Likewise, the simple model of an ordered mechanism with FMN binding first was
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Figure 4.7. Dependence of radioactivity in blanks on [Mg2+]. The curve represents 
the best fit through the data using an exponential curve and is for visualization 
purposes only. The dark triangle represents the original [Mg2+] used in early 
experiments.
not accepted as a reasonable model. In Figure 4.8.B, a clear pattern is observed where the 
residuals move from negative at low reciprocal values, to positive then to negative at 
higher reciprocal values. The trend one would expect for a good fit would be a nearly 
linear line around 0 with slope 0. Thus, the observed trend indicates the true model has 
curvature. There is no obvious trend in Figure 4.9.B. However, the residuals of the 
individual concentrations of IPP are not randomly distributed around zero. Instead, they 
tend to be either all negative or all positive, an indication that the best-fit lines are not 
actually going through the data points. Examination of the Michaelis-Menten plots based 
on the above parameters shows that the fits are very poor (Figure 4.10.A and Figure 
4.10.B). A better fit was achieved when the data were fit with a sigmoidal function 
(Figure 4.10.C and Figure 4.10.D). Together, this evidence excludes the sequential,
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Figure 4.8. Reciprocal plots for ^^-IDI-2 bisubstrate kinetics with variable FMN. A, 
Reciprocal plot with best fit lines for an ordered mechanism with FMN binding 
first; B, Residual plot of the residuals from the fit in A with a trend line displaying 
the patterns of residuals for varying FMN concentration.
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Figure 4.9. Reciprocal plots for ^^-IDI-2 bisubstrate kinetics with variable IPP. A, 
Reciprocal plot with best fit lines for an ordered mechanism with FMN binding 
first; B, Residual plot of the residuals from the fit in A with a trend line displaying 
the patterns of residuals for varying IPP concentration.
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Figure 4.10. Michaelis-Menten plots for the bisubstrate kinetics of ^ ^-IDI-2. A, Best 
fit lines for variable FMN using the parameters in the text for a sequential ordered 
model with FMN binding first; B, Best fit lines for variable IPP using the 
parameters in the text for a sequential ordered model with FMN binding first; C, 
Best fit lines for variable FMN using a Gompertz growth model; D, Best fit lines for 
variable IPP using a Gompertz growth model. Note: the fits to the Gompertz 
equation were not multivariate fits and are for visualization only.
ordered model with FMN binding first as an inadequate description for the kinetic 
mechanism of Sp-IDI-2.
Two models were used that more appropriately describe the bisubstrate kinetic 
data. The first model is a modified ordered multiple essential activator and multiple 
substrate binding site model (Eq. 4.4), where A represents FMN, S represents IPP, and n 
and m are Hill coefficients.158 With this model, FMN is treated as an activator such that n 
molecules of FMN bind before any IPP binds. In other words, n molecules of FMN are 
independently in equilibrium with IDI-2 and m molecules of IPP bind only to the 
FMNn*IDI-2 complex. The parameters from this fit are shown in Table 4.3. The 
Michaelis-Menten plots and reciprocal plots are shown in Figure 4.11.
The next model fitted to the data was the common ordered binding equation, with 
FMN binding first, modified to include Hill coefficients (Eq. 4.5). As in the previous 
model, A represents FMN, S represents IPP, and n and m are Hill coefficients. With the 
modification, the assumption is that n molecules FMN are simultaneously in equilibrium 
with IDI-2 and bind before IPP. Then m molecules of IPP are simultaneously in 
equilibrium with the FMNn*IDI-2 complex. The results from this fit are in Table 4.4. The
Table 4.3. Kinetic parameters for »Sp-IDI-2 fit to a modified ordered multiple 
essential activator and multiple substrate binding site model.
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Mean S.E. 95% C.I.
kcat (s 1) 1.11 0.08 (0.98, 1.29)
Kipp (^M) 23.3 4.0 (16.0, 32.4)
Kfmn (^M) 1.61 0.49 (0.89, 2.99)
m 1.14 0.02 (1.10, 1.19)
n 2.59 0.34 (2.07, 3.45)
Residual Sum of 
Squares 2.167
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Figure 4.11. Plots for ^^-IDI-2 bisubstrate data with best fit lines to the modified 
ordered multiple essential activator and multiple substrate binding site model. A, 
and B, Michaelis-Menten plots for variable FMN and IPP, respectively; C, and D, 
Reciprocal plots for variable FMN and IPP, respectively.
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Table 4.4. Kinetic parameters for »Sp-IDI-2 fit to a modified ordered multiple 
substrate binding site model.
Mean S.E. 95% C.I.
kcat (s 1) 0.983 0.078 (0.845, 1.162)
Kipp (^M) 40.8 5.6 (30.8, 53.5)
Kfmn (^M) 2.39 0.26 (1.98, 3.07)
m 1.15 0.02 (1.10, 1.19)
n 1.95 0.09 (1.79, 2.12)
Residual Sum of 
Squares 1.978
plots of Michaelis-Menten and reciprocal fits are shown in Figure 4.12. Both models fit 
the bisubstrate data well with low residual sums of squares. The parameter values for 
both models are similar. Thus, models that require a Hill coefficient and treat FMN as the 
first substrate to bind support the data.
Inhibition studies were performed that comprehensively described the Sp-IDI-2 
kinetic mechanism and supported the previously described bisubstrate fits. Adonitol was 
examined as a competitive inhibitor of FMN, however was not inhibitory even at 
millimolar concentrations. Lumichrome was also studied as it successfully inhibited 
NADH:flavin oxidoreductase, an enzyme that uses FMN as a substrate.164,165 
Solubilization of lumichrome in pyridine resulted in a 90 % decrease in catalytic 
efficiency. When dissolved in NaOH, no change in kinetic parameters was observed for 
the control, but an inhibitor was desired that did not require changing the assay 
conditions. Thus, 5-deazaFMN was explored.
In order to fit the data obtained from 5-deazaFMN inhibition of FMN, the 
standard competitive inhibition equation was modified to include Hill coefficients (Eq. 
4.6) to yield the curves shown in Figure 4.13. From this fit, 5-deazaFMN was a potent
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Figure 4.12. Plots for ^ -ID I-2  bisubstrate data with best fit lines to the modified 
ordered with FMN binding first model. A, and B, Michaelis-Menten plots for 
variable FMN and IPP, respectively; C, and D, Reciprocal plots for variable FMN 
and IPP, respectively.
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Figure 4.13. Plots of ^ ^-IDI-2 inhibition with 5-deazaFMN and variable FMN with 
data fit to a modified competitive inhibitor equation. A, Michaelis-Menten plot; B, 
Reciprocal plot.
inhibitor of FMN with a K  of 75 nM (Table 4.5). Each Hill coefficient for FMN and 5- 
deazaFMN is the same, and each is half the Hill coefficient for FMN in the bisubstrate 
essential activator model (Table 4.3). Whether this is significant or just a coincidence is 
unclear.
When 5-deazaFMN was evaluated with IPP as the varied substrate, data were fit 
to a modified noncompetitive inhibitor model (Eq. 4.7, Figure 4.14). With this fit, the Hill 
coefficient of IPP had a 95% confidence interval of (0.72, 1.43), which includes 1.0. 
Thus, this parameter was not included and the data were refit to give the results in Table
4.6 under the "Original Analysis" column. The fits to the data reveal a problem where the 
fit poorly matches the data at no or low 5-deazaFMN concentrations. To account for this, 
a new term, Kppi, was included to account for equilibrium binding of IPP to the 5- 
deazaFMN*IDI-2 complex as shown in Figure 4.15. Here IPP is assumed to bind 
differently to the active FMN*IDI-2 compared to the inhibitor complex.
When the new term was included (Eq. 4.8), the residual sum of squares decreased 
by half (Table 4.6, “Subsequent Analysis”). However, the parameter values shifted from 
the previously observed results in the bisubstrate studies. For example, the original Kipp 
parameter increased from 61 to 224 |iM when the new parameter was added, while for 
the bisubstrate study the value was 41 |iM. While adding a new parameter improved the 
fit, the changes in the parameter values may be an indication that Figure 4.15 is not an 
appropriate model either.
To complement the results of the FMN competitive inhibitor pattern, a 
competitive inhibitor for IPP was evaluated. First, cyclopropyl-IPP was evaluated, but 
because it functions as an alternate substrate,166 the results were more convoluted than
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Table 4.5. Kinetic parameters for 5-deazaFMN inhibition of FMN for ^p-IDI-2 fit to 
a modified competitive inhibition model.
Mean S.E. 95% C.I.
kcat (s 0.833 0.134 (0.636, 1.261)
Ki (nM) 75.0 5.8 (63.6, 86.9)
Kfmn (^M) 3.55 0.71 (2.53, 5.86)
n 1.31 0.05 (1.22, 1.42)
d 1.34 0.08 (1.18, 1.53)
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Figure 4.14. Plots of ^ ^-IDI-2 inhibition with 5-deazaFMN and variable IPP with 
data fit to a modified competitive inhibitor equation. A, Michaelis-Menten plot of 
the Original Analysis; B, Reciprocal plot of the Original Analysis; C, Michaelis- 
Menten plot of the Subsequent Analysis; D, Reciprocal plot of the Subsequent 
Analysis.
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Table 4.6. Kinetic parameters for 5-deazaFMN inhibition of IPP for ^p-IDI-2. 
Original Analysis are results from a fit to Eq 7. Subsequent Analysis are results 





Mean S.E. 95% C.I.
kcat (s )^ 0.866 0.070 (0.740, 1.021) 1.86 0.32 (1.38, 2.77)
Kipp (m*M) 60.7 7.6 (47.2, 77.8) 224 51 (149, 369)
Ki (nM) 68.3 6.8 (55.8, 82.2) 201 37 (143, 318)
d 1.35 0.09 (1.19, 1.54) 1.44 0.07 (1.31, 1.57)
Kippi (^M) -- 15.8 4.3 (7.9, 25.6)
Residual Sum 
of Squares 3.198 1.456
E + mS ,  ESm mkcat »  E + mP 
+ 
dl
^  KEId + mS EldSm
Figure 4.15. Proposed model for the noncompetitive inhibition of IPP by 5- 
deazaFMN.
desired. The T. thermophilus IDI-2 potent inhibitor Cl-IPP was examined, but as 
previously described, reproducibility was a problem.167 Previously, NIPP was a 
demonstrated inhibitor of T. thermophilus IDI-2 with a Ki = 5.1 |iM,63 and thus was 
evaluated for the S. pneumoniae enzyme.
The data from NIPP inhibition of IPP could be fit to the standard competitive 
inhibition model (Eq. 4.6, without the n and d  parameters) to yield the best-fit curves in 
Figure 4.16. When Hill coefficient parameters were included, either the fit did not
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Figure 4.16. Plots of ^ - ID I-2  inhibition with NIPP and variable IPP with data fit to 
a competitive inhibitor equation. A, Michaelis-Menten plot; B, Reciprocal plot.
improve significantly or the 95% confidence interval of that parameter included 1.0 (an 
indication the parameter was insignificant). Here, the large Kipp is similar to the value 
obtained for the 5-deazaFMN inhibition experiment under the “Subsequent Analysis” fit 
(Table 4.7).
Assessing NIPP as an inhibitor of FMN, the reciprocal plots showed data that 
were parallel at different NIPP concentrations but curved (Figure 4.17). Thus the data 
were fit to a modified uncompetitive model to account for the curvature (Eq. 4.9). As 
observed with all studies of variable FMN, an exponent was needed to properly fit the 
data and the value was ~ 2 (Table 4.8).
Cumulatively, the pattern of the FMN competitive inhibitor (competitive for FMN 
and noncompetitive for IPP) and the pattern of the IPP competitive inhibitor (competitive 
for IPP and uncompetitive for FMN) indicate that the sequential binding occurs with 
FMN binding first followed by IPP binding.168
Discussion
The discovery of the MEP pathway of isoprenoid biosynthesis has introduced a 
number of new enzyme antibacterial drug targets. These enzymes are necessary for the 
pathogenic organisms that express them, but are not found in Homo sapiens. While not 
exclusive to the MEP pathway, IDI-2 is found in several pathogenic organisms, including 
Staphylococcus aureus, Enterococcus faecalis, and Streptococcus pneumoniae 45 Like the 
enzymes of the MEP pathway, IDI-2 has been proposed as a potential drug target due to 
the absence of a homologue in humans. Despite the appeal of IDI-2 as a drug target, there 
have been limited studies on the enzyme from pathogenic organisms.
The Sp-IDI-2 enzyme was previously selected as a potential antibacterial agent
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Table 4.7. Kinetic parameters for NIPP inhibition of IPP for »Sp-IDI-2 fit to a 
competitive inhibition model.
Mean S.E. 95% C.I.
kcat (s 1) 1.47 0.10 (1.29, 1.70)
Ki (^M) 15.5 1.2 (13.3, 18.0)
Kipp (^M) 184 23 (144, 236)
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Figure 4.17. Plots of ^ p-IDI-2 inhibition with NIPP and variable FMN with data fit 
to a modified uncompetitive inhibitor equation. A, Michaelis-Menten plot; B, 
Reciprocal plot.
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Table 4.8. Kinetic parameters for NIPP inhibition of FMN for ^p-IDI-2 fit to a 
modified uncompetitive inhibition model.
Mean S.E. 95% C.I.
kcat (s 0.736 0.021 (0.699, 0.782)
Ki (^M) 11.4 0.6 (10.4, 12.6)
Kfmn (^M) 1.19 0.04 (1.12, 1.28)
n 2.12 0.13 (1.88, 2.37)
and crystallized.163 During preliminary studies, flavin was released from the enzyme 
while purified on a Ni2+ affinity column. However, these results were inconsistent and 
not reproducible with different columns and wash procedures. To ensure complete 
deflavination, a 2 M KBr wash was added to the purification method. Reconstitution, if 
necessary, required incubation with FMN and washes with buffer through an 
ultrafiltration device.163 These properties of Sp-IDI-2 differ from the T. thermophilus 
enzyme in that the Tt-IDI-2 lost the ability to be reconstituted once deflavinated.
The ease at which FMN released from Sp-IDI-2 introduced the possibility that 
FMN functions as a substrate in the overall reaction. Bisubstrate kinetic studies have a 
long history used in conjunction with competitive substrate inhibitors to elucidate the 
overall bisubstrate kinetic mechanism.168 Applying these techniques, a mechanism was 
uncovered that is both well described by the data (a sequential, ordered mechanism, with 
FMN binding first) and unique (Hill coefficients were necessary for proper fitting).
Based on crystal structures of the S. shibitae IDI-2, it seemed apparent that FMN 
bound in the active site before IPP because FMN was located deeper in the binding 
pocket.58,73 Furthermore, IDI-2 has routinely been purified with FMN still bound from 
some organisms including Methanocaldococcus jannaschii,169 and Thermus 
thermophilus.63
The bisubstrate kinetics of Sp-IDI-2 exhibited curvature that a simple bisubstrate 
model could not explain. Likewise, when substrate concentration was plotted against 
velocity, the data did not approach zero in a direct hyperbolic manner. A simple equation 
was desired that would describe the data without including complex or unnecessary 
characteristics. In one attempt to fit the data, a multiple essential activator equation was 
applied. However, the meaning of the coefficients differed from those of the inhibition 
results. While the multiple essential activator fit may help explain some characteristics of 
the mechanism, the model is not completely adequate. Modification of the sequential, 
ordered bisubstrate equation with Hill coefficients improved the fit and made all the 
results consistent. For example, the Hill coefficient for FMN in every study was ~ 2, 
except when inhibited by 5-deazaFMN when it was 1.3. The literal, but unrealistic 
interpretation of the Hill coefficients would be that two molecules of FMN 
simultaneously bind with apo-IDI-2. More reasonable is the idea that two molecules of 
FMN bind before IPP based on the successful fitting of the multiple essential activator 
model with a coefficient of 2.6. Here the value represents a summation of the population 
in the steady state and thus, there are two or three FMN molecules bound to IDI-2 before 
IPP binds.
The addition of Hill coefficients was one way to describe the data, but these 
results will not be used to extrapolate the exact mechanism. While Hill coefficients are 
convenient to mathematically fit data, their ineffectiveness to establish a definitive 
mechanism is well described.170 The complexity of data and nonlinear fits provides 
confidence that the system undergoes cooperativity or allostery. The results are consistent 
with a type of cooperativity that would be positive in nature. Since the Sp-IDI-2 enzyme
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is a tetramer in solution,163 these subunits likely interact in a process that is necessary for 
catalysis. Hemmi and coworkers found that addition of substrate caused the octomer of S. 
shibatae IDI-2 to degrade into a tetramer.59 Based on unpublished results from our group, 
a monomer can be produced that is also active, which supports an allosteric rather than a 
cooperative effect.
The presence of an allosteric effect raises new possibilities beyond just active site 
targeted drugs. To date, there are no crystal structures of an IDI-2 enzyme without FMN 
bound. Determination of the effects that take place upon FMN binding may be important 
to understand the observed bisubstrate kinetics.
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CHAPTER 5
BOOTSTRAP ANALYSIS OF TRANSIENT KINETIC ISOTOPE 
EFFECTS IN FARNESYL SYNTHASE AND 
PROTEIN FARNESYL TRANSFERASE
Introduction
Farnesyl diphosphate (FPP) synthase catalyzes a head-to-tail condensation of IPP 
and DMAPP to form geranyl diphosphate (GPP). In a similar manner, FPP synthase 
(FPPase) can condense GPP and another molecule of IPP to form FPP, which begins the 
isoprenoid chain-elongation pathway. The FPPase enzyme contains a core scaffold of 10 
a helices that have been termed the “isoprenoid fold” because of their ubiquity in the 
isoprenoid family of enzymes.171 The universality of the structural fold found in FPPase 
leads it to be an ideal model to understand the chemistry of reactions in the isoprenoid 
biosynthetic pathway.
Based on protein sequences in the human genome, hundreds of prenylated 
proteins have been predicted that vary in their function from processes such as 
centromeric proteins, proteins involved with cell cycle regulation and apoptosis, glycogen 
metabolic enzymes, and GTPases of the Ras superfamily.172 The Ras proteins, which are 
part of the signaling pathway that controls cell proliferation, are substrates of protein 
farnesyl transferase (PFTase). Nearly one-third of human cancers are linked to mutated 
Ras proteins and within that, K-Ras mutations are found in half the colorectal cancers and
almost all (90 %) of pancreatic cancers.34 PFTase catalyzes the farnesylation of a cysteine 
residue at the C-terminal of a protein that contains a motif called the CAAX box, where 
A represents an aliphatic amino acid and X is a variable amino acid site. The reaction 
occurs as the cysteine’s zinc coordinated sulfur displaces the phosphate oxygen from C1 
of FPP. Evidence that describes the nature of this displacement supports both 
dissociation,173,174 and association,175-177 or is substrate dependent.178 Understanding the 
transition state structure of PFTase will help investigation into inhibitors that may be 
used as anticancer drugs.
Currently, investigations into the FPPase and PFTase transition state structures 
focus on transient kinetic studies, particularly transient kinetic isotope effects (TKIE). 
The time and signal dependency of transient kinetics requires a different analytical 
approach than when steady state kinetic isotope effects (KIE) are studied. Fisher and co­
workers developed a set of rules that can be applied to transient kinetics to determine the 
intrinsic KIE (KIEint) with stopped-flow experimentation.179 While they neglected a 
quantitative determination of error in their examples, variability of TKIEs can be 
described using the bootstrap.
The bootstrap is a computer intensive statistical technique that, for the purposes of 
this chapter, is nonparametric (no assumptions are made regarding the nature of the 
population distribution). With this technique, a sample is made (with replacement) from a 
given set of data, and the parameter of interest is calculated. As an example, a dataset is 
in Table 5.1 where the linear relationship between X and Y is of interest. In this 
simplified example, the slope (0.244 ± 0.029 calculated from Eq. 5.1 and 5.2) and 
intercept (0.448 ± 0.177 calculated from Eq. 5.3 and 5.4) are easily calculated since each
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Table 5.1. Example linear regression data (Original columns) with samples of those 
data taken with replacement.
Original Sample 1 Sample 2
x y x y x y
1 0.803 2 0.863 7 2.19
2 0.863 7 2.19 7 2.19
3 1.32 8 2.12 8 2.12
4 1.48 3 1.32 3 1.32
5 1.76 9 2.99 8 2.12
6 1.38 9 2.99 10 2.98
7 2.19 2 0.863 8 2.12
8 2.12 10 2.98 5 1.76
9 2.99 5 1.76 3 1.32
10 2.98 5 1.76 8 2.12
Slope 0.267 0.196
Intercept 0.381 0.713
Sample 3 Sample 4 Sample 5
x y x y x y
6 1.38 4 1.48 8 2.12
5 1.76 10 2.98 1 0.803
7 2.19 1 0.803 2 0.863
7 2.19 6 1.38 9 2.99
7 2.19 6 1.38 6 1.38
10 2.98 6 1.38 2 0.863
3 1.32 10 2.98 4 1.48
7 2.19 5 1.76 6 1.38
10 2.98 1 0.803 6 1.38
10 2.98 7 2.19 10 2.98
0 257 0.242 0.243
0 369 0.548 0.312
has an explicit solution.
slope =  m =
l ( X i - x y
5.1
slope s tan d a rd  deviat ion =
MSE
I W i - x ) 2
5.2
intercept  =  b =  Y — mX 5.3
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intercept  s tan d a rd  deviat ion =  IMSE ( — +
2
E f t  - Z )  el
MSE =
n 'L(Xi - X ) 2
2 5.5
n — 2 n — 2
Also in Table 5.1 are five random samples from the original dataset. These 
samples were taken with replacement, so each data point could be sampled multiple 
times. For example, in Sample 1 data points (9, 2.99) and (5, 1.76) were each sampled 
twice. The slope and intercept for each sample are also shown in Table 5.1 below the 
sampled data (for the bootstrap, the variability is not determined at this stage). Next, the 
mean and standard deviations of these slope and intercept values are calculated. For this 
example, the slope is 0.241 ± 0.027 and intercept is 0.465 ± 0.164. These are the 
bootstrap statistics and are an estimate of the sample distribution; note how similar the 
parameters and their variability are compared to the explicitly determined values above.
The original data could be sampled any number of times, but usually a good 
estimate is achieved quickly, as in the above example with only five samples of the data. 
With 100 samples (not shown), the slope is 0.240 ± 0.031 and the intercept is 0.457 ± 
0.140. A bootstrap replicate is performed each time the original data are sampled and a 
parameter calculated. The collection of these values will form a distribution that 
approximates the true distribution (Figure 5.1). From a collection of bootstrap replicates, 
the mean and variability can be approximated. In a bootstrap analysis, an influential data 
point is one that causes the distribution to shift significantly in one direction. For 
example, an influential data point may cause a bias where slope values are calculated 
only when it is selected in the bootstrap replicate (slope < 0.15, Figure 5.1.B). Removal
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Figure 5.1. Histograms of the 100 bootstrap values from the linear regression 
example. Curves represent the normal curves with mean and standard deviations 
discussed in the test. A, Intercept values; B, Slope Values.
of this point would correct the skew in the distribution and provide for a more realistic 
approximation to the true distribution.
Importantly, some considerations were overly simplified for the previous 
example. In the previous example, it would be desirable to perform the experiment 
another four to six times to have an appropriate dataset. Even though the parameters were 
well approximated, replicates on the entire experiment will help the analyst understand 
the experiment-to-experiment variability. Another consideration is that the bootstrap does 
not create data. It just examines the data in a different way than traditionally performed.
While simple statistics, such as slope, have a well-known and understood formula 
and associated error structure, many parameters such as a KIE (because it is a 
combination of individually determined parameters, see Experimental Procedures), 
deviate from that ideal situation. In moving away from ideality, the associated theory and 
statistical foundation for the variability of a parameter become convoluted, complicated, 
and in some situations impossible to explicitly determine. A primary advantage of the 
bootstrap to other statistical methods is its simplicity and the use of data that have already 
been generated to estimate a statistic that may otherwise be extremely difficult to solve.
The following describes the application of the bootstrap to determine the KIEint 
for both FPPase and PFTase. The error and confidence limits associated with the KIEint 
parameter will be presented. The importance of an appropriate determination of error will 
be discussed.
Experimental Procedures
Source o f data. The farnesyl synthase data were provided by Dr. Leigh-Anne 
Ferguson-Ihnken (APPENDIX A). Data for the farnesyl transferase experiments were
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provided by Dr. Seoung Choi (APPENDIX B).
Derivation o f transient kinetic isotope effect equation. The turnover ratio was fit 
to a first order growth model Eq. 5.6 that forced an intercept at the origin, where: yi, ti, 
and si, are the response, time and error, respectively, for data point i; m is the response 
from the deuterated (D) or unlabeled (H) substrates; and am and km are parameters of the 
exponential function.
y t =  am(1 -  exp-fcmtQ + ef 5.6
Finding the derivative of Eq. 5.6 with respect to time, gives Eq. 5.7.
d y i / d t  =  - a mkmexp-kmti +  £■ 5.7
The TKIE model (Eq. 5.8),179 is only dependent on the derivatives of the signals 
sh and sd for the unlabeled and deuterated substrate, respectively. The derivative 5.7 is 
substituted into 5.8 to yield 5.9.
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d[sH] / d t  5.8
TKIEV =
d[sD] / d t
aHkHexp kHti +  e'Hi aHkHexp kHti 5.9
aDkDexp-koti +  e'Di aDkDexp-koti H,t
Taking the limit as t  ^  0, gives Eq. 5.10 which, according to the First Rule of 
Transient-State KIEs, is equal to the intrinsic KIE.180
l imTKIE = - : -  =  KIEIntrinsic t^o aDkD
U u k u  5.10
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Statistical analysis. Data analysis was performed using the boot package in R 
version 2.11.0 or later,117 with the additional packages boot,181,182 dichromat,121 
ggplot2,183 grid,117 nlstools,159 and spatstat.184
Results
Source o f data and statistical analysis. A single turnover kinetic study was 
performed with both FPPase and PFTase using unlabeled and CD3-labeled substrates 
(Figure 5.2). The amount of unlabeled and CD3-labeled substrates and products that 
remained after a reaction were separated with HPLC and quantified as disintegrations per 
minute (DPM) from a scintillation counter. The turnover ratio (the signal) was calculated 
and fit to a single exponential growth model, Eq. 5.6. The choice of model fit to the data 
is irrelevant, as long as the model is the same for both the labeled and unlabeled analysis, 
and the derivative can be calculated.179 No intercept correction was included in the single 
exponential growth model because the confidence interval of the intercept parameter 
included zero, an indication that it was an unnecessary parameter.
A balanced approach was used to ensure that over the entire analysis, regardless
9 10 13 14 15
unlabeled GPP unlabeled FPP
CD3-GPP c d 3-f p p
Figure 5.2. Structures of unlabeled GPP and FPP (* denotes a 14C label) and 
deuterated methyl-GPP and FPP with a 3H label. The unlabeled term refers to the 
C9 and C13 methyl groups only and does not refer to the radioactive labels.
of the number of bootstrap replicates, each data point was used an identical number of 
times. Sampling with time-point stratification retained the initial number of time points 
for each bootstrap replicate, which ensured that full exponential curves were evaluated 
(this would exclude a hypothetical bootstrap replicate that contains only sampling from a 
single time point).
For each analysis, an initial fit was performed to both the deuterated and 
unlabeled data and residuals were identified (Figure 5.3.A and Figure 5.4.A). While the 
bootstrap analysis is resistant to outliers, three points in the farnesyl synthase dataset had 
standardized residuals with absolute values > 3. Closer inspection revealed that one point 
was an outlier for both experiments and the others were outliers in just one of the 
experiments. The fit was repeated where the paired outlier was kept in the analysis while 
the individual outliers were considered statistically significant outliers and were removed 
(Figure 5.3.B). Initial analyses with the bootstrap indicated that influential data were 
present and should be removed, similar to an outlier in a regression analysis. The removal 
of influential data was only performed once (Figure 5.3.C and Figure 5.4.B). A number 
of bootstrap replicates were evaluated for each study, ranging from 100 -  250,000. 
However, 10,000 replicates were satisfactory and produced results that were identical to 
three significant digits of different numbers of replicates. Thus, all following results and 
discussion will refer to the 10,000 replicate results.
The KIEint values for both enzymes were determined to be significantly greater 
than 1 (Table 5.2), an indication that a kinetic isotope effect was observed. Several plots 
are presented as diagnostic checks on the bootstrap analysis to ensure that the bootstrap 
was both properly executed and the results obtained are statistically relevant. Plots of the
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Figure 5.3. Product formation plots for FPPS. Dark solid lines and circles represent 
unlabeled GPP results. Gray, dashed lines and squares represent CD3-GPP results. 
A, First plot of the data; B, Plot after removing two outliers; C, Final plot after 
removing influential data.
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Figure 5.4. Product formation plots for PFTase of the average result at each time 
point and the best fit lines. Dark solid lines and circles represent unlabeled FPP 
results. Gray, dashed lines and squares represent CD3-FPP results. A, First plot of 
the data; B, Plot after removing influential data.
jackknife values for the initial and final analysis for both enzymes are shown in Figure 
5.5. These plots identify influential data in a bootstrap analysis. In Figure 5.5.A, the first 
analysis of the FPPase data revealed two points that were significantly influencing the 
distribution (37 and 55). Likewise, with the PFTase data, Figure 5.5.B shows three 
influential points (31, 43 and 60). After these points were removed and the bootstrap 
repeated, some more points were revealed as influential. However, the analysis was
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Table 5.2. Summary of results comparing the bootstrap to a nonlinear analysis. 
Nonlinear indicates a nonlinear determination of the KIEint based on all the data 
pooled together. Initial is the parameter value before any data were removed (for 
FPPase bootstrap, after outliers were removed). Final is the parameter value after 
outliers (for Nonlinear analysis) and influential data (for Bootstrap analysis) were 
removed. S.E. is standard error of the KIEint. 95% BCa C.I. is the 95% bias- 
corrected accelerated confidence interval.
Stage of 95% BCa C.I.









1.374 0.115 1.207 1.690







Bootstrap 0.019 1.009 1.085Final 1.053 0.013 1.029 1.081
stopped after the second bootstrap. Histograms of all KIEint values from the bootstrap 
replicates are shown in Figure 5.6. The initial data were not expected to be normally 
distributed because of the presence of influential data that will skew the distribution. 
Once the points described above were removed and the analysis repeated, and in support 
of properly produced results, the final plots of both enzymes studied appear normally 
distributed. Note that for the FPPase enzyme (Figure 5.6.A), the influential points in the 
first analysis skewed the results and caused a high KIEint value, visible by the poor fit of 
the normal curve over the distribution. For the PFTase enzyme (Figure 5.6.B), the 
influential points caused a low KIEint value. However the poor fit of the normal curve is 
not as visible.
The collection of curves produced in all 10,000 bootstrap replicates are in Figure
5.7 and Figure 5.8 for the FPPS data and Figure 5.9 and Figure 5.10 for the PFTase data. 




Figure 5.5. Jackknife-after-boot plots. A, FPPase. The first (after outliers were 
removed) and final bootstraps are indicated by * and x, respectively; B, PFTase. The 
first (after outliers were removed) and final bootstraps are indicated by * and x, 














Figure 5.6. Histograms of bootstrap results. A, FPPase. The first bootstrap (after 
removing outliers) is in green. The second bootstrap (after removing influential 
data) is in magenta; B, PFTase. The first bootstrap is in blue. The second bootstrap 
(after removing influential data) is in red. Curves represent a normal curve with 
mean and standard deviation of the corresponding data.
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Figure 5.7. Signal derivative curves for the final analysis of FPPase. Unlabeled 
substrate curves are in brown, CD3-GPP curves are blue. The bold dotted 
(unlabeled) and dashed (deuterated) curves represent the average of their respective 
curves.
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Figure 5.8. Superimposed TKIE curves for the final analysis of FPPase. A, Black 
represents the highest density and white represents the lowest; B, Dark purple 
represents the highest density and green represents the lowest. The individual 
curves represent one bootstrap replicate.
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Figure 5.9. Signal derivative curves for the final analysis of PFTase. Unlabeled 
substrate curves are in brown, CD3-FPP curves are blue. The bold dotted 
(unlabeled) and dashed (deuterated) curves represent the average of their respective 
curves.
153
Figure 5.10. Superimposed TKIE curves for the final analysis of PFTase. A, Black 
represents the highest density and white represents the lowest; B, Dark red 
represents the highest density and blue represents the lowest. The individual curves 
represent one bootstrap replicate.
functions and the TKIE function. With the derivative functions of both enzymes, the 
unlabeled substrate curves are larger at lower time points as they go to zero, indicating an 
observed normal KIE. The functions then decrease until they intersect and switch 
positions so the deuterated substrate curves are larger than the unlabeled curves. This 
pattern in the relationships of deuterated and unlabeled substrates in the derivative curves 
is visible in the TKIE plots.
The TKIE plots show the density of the curves from the bootstrap analysis. Here 
the majority of TKIE values start out larger than 1.0, then pass through 1.0 (where the 
derivative functions intersect) and continue decreasing, while some appear to 
continuously increase (Figure 5.10). Notice that these curves are not uniformly 
distributed across time. In both datasets, the curves start out dispersed around t = 0, then 
condense into a collection of curves that appear darker and then spread out at higher time 
points.
Discussion
The bootstrap technique, first described in 1979,185 now has a well-established 
and rigorously studied history. The bootstrap is frequently applied in designing 
phylogenetic trees, a result of a classic paper that resolved the problem of relating 
organisms with only a single DNA sequence sample from a species.186 Other fields have 
also incorporated the bootstrap, such as psychology,187 economics,188 and ecology.189 
While there is literature precedence for the application of the bootstrap to problems of a 
chemical nature, the application is sparse. One reason for this limited application may be 
the vigorous, explicit solutions desired by the physical sciences. The bootstrap is a 
nonparametric technique, meaning that there is not necessarily an explicit solution to a
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parameter of interest. The unavailability of an explicit solution may be the result of a yet 
unsolved, complex or impossible analytical solution to a parameter. For example, with 
equation 5.10, each parameter has an associated error, which can be determined from a 
nonlinear fit. However, when each parameter is combined as in equation 5.10, the TKIE 
variability becomes convoluted. Visually, we can see the heterogeneous variability in 
Figure 5.8 and Figure 5.10.
The transient-state kinetic isotope effect approach has received limited 
acknowledgement in the literature, perhaps because of the difficulty in determination of 
the error associated with the TKIE parameter. In early papers that evaluated TKIE values, 
estimates o f error were made with an assumption of only 2% error caused by 
pipetting.179,190 Another paper added and subtracted standard error from the mean value 
of fitted parameters to determine maximum and minimum TKIE values.191 To my 
knowledge, the exploration of error in transient-state kinetic isotope effect studies has not 
been further evaluated or estimated.
The bootstrap approach was applied to estimate the intrinsic KIE in a transient- 
state KIE experiment. Furthermore, the body of data collected in the bootstrap replicates 
was used to visualize the confidence intervals. With PFTase, all data had been collected 
before analysis started, but with FPPase, data were collected and immediately analyzed. 
Once enough data were collected to obtain a consistent KIEint value, experimentation was 
ceased.
Based on unpublished results from our group, the KIEint values obtained with the 
bootstrap technique are 100 % greater than predicted using computational techniques. For 
example, the computed KIE was 1.1 for the predicted reaction that occurs with the
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FPPase enzyme (a resonance stabilized [9-D3]-geranyl cation, see Figure 5.2). However, 
the bootstrap determined a value of 1.24 with a 95 % BCa C.I. of (1.14, 1.37). 
Knowledge of the error in this parameter helped to reexamine the experimental design. 
Future experiments will attempt a different approach than using radiolabeled compounds.
While the approach presented here focused on the analysis of transient-state KIE 
experiments, the methodology may be extended to steady-state KIE experiments. Steady- 
state KIE values are by their nature a complicated parameter to determine with numerous 
sources of error. Unfortunately, there is limited description of how to determine the error 
of in a KIE value. A suggestion, and perhaps the practice, is to conduct separate KIE 
experiments, calculate KIE for each, then average these values for the mean and standard 
deviation.192 While this is a reasonable approach, there is a loss of information when the 
within experiment error is ignored.
An important note must be addressed about careful data fitting with the transient 
kinetic isotope effect equations. One powerful aspect of equation 5.8 is the inherent 
model independence, meaning that the model fit to the observed signal is irrelevant, as 
long as that model is the same for the numerator and denominator and a limit exists as 
t  ^  0. For example, there are many models that can be used to describe a growth curve 
such as an exponential, biexponential, Gompertz, logit, Richards and so on. The caution 
concerns overfitting and appropriately fitting the observed data. The first data analysis 
with the FPPase data revealed a lag phase that fit well to the three-parameter Gompertz 
equation (Eq. 5.11). Following a similar analysis as above, a KIEint of
y t =  aexp(bexp(cti)) +  et 5.11
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1.217 ± 0.063 was determined. These results concur with the results in Table 5.2 for 
FPPase. However, a lag phase indicates that chemistry is not the rate limiting step and 
instead the binding of enzyme and substrate are rate limiting. The single turnover kinetics 
of DNA helicase yield a lag phase, the magnitude of which is dependent on the length of 
double stranded DNA that is unwound.193 Thus, the process of DNA unwinding has 
multiple steps, some of which are rate limiting. In another case, a lag phase was observed 
in single turnover kinetic studies of tryptophan synthase when both substrates of the 
bisubstrate reaction were simultaneously added to the enzyme.194 However, with 
preincubation of the first substrate that binds with the enzyme before addition of the 
second substrate, the lag phase was eliminated. Similarly, our group determined that 
preincubation was necessary for the same reason, and thus no lag phase should be 
present. Upon further examination, a discovery was made that a blank correction was 
omitted during data analysis. Once the correction was applied, the results listed in Table
5.2 were obtained. If the blank corrected data were analyzed using the Gompertz 
equation, after outlier and influential data elimination (the same points were determined 
to be outliers and influential as that for the single exponential model), the result is a 
KIEint = 1.248 ± 0.068. This result is nearly the same as that in Table 5.2, but the 
uncertainly is higher for the three-parameter model, an indication that the model is 
overfit. Practically, the Gompertz model was not the correct model for the chemistry 
taking place and thus the single exponential model was used.
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APPENDIX B
MASS SPECTRA AND CHROMATOGRAMS OF 
ISOPRENE-FMN ADDUCT
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MS 1. Negative ion TOF ESI Mass spectrum of ZrCh purified FMN from IDI-2 after a 21 d incubation without substrate.
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m/z
MS 2. Negative ion TOF ESI Mass spectrum of graphite purified FMN from IDI-2 after a 21 d incubation without substrate.
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MS 3. Negative ion TOF ESI Mass spectrum of ZrCh purified FMN from IDI-2 after a 21 d incubation with IPP.
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MS 6. Negative ion TOF ESI Mass spectrum of FMN isolated from IDI-2 after a 24 h incubation with DMAPP.
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MS 8. Negative ion TOF ESI Mass spectrum of FMN isolated from IDI-2 after a 24 h incubation without substrate. 170
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MS 11. Negative ion TOF ESI Mass spectrum of FMN isolated from IDI-2 after a 27 d incubation with FPP.
MS 12. UPLC-MS chromatograms of a 24 h incubation of 7Y-IDI-2 without substrate of masses 255.2 (red), 375.2 (orange),




MS 13. UPLC-MS trace at 2.4 min of a 24 h incubation of 7Y-IDI-2 without substrate.
MS 14. UPLC-MS trace at 2.9 min of a 24 h incubation of 7Y-IDI-2 without substrate.
O n
MS 15. UPLC-MS trace at 4.0 min of a 24 h incubation of 7Y-IDI-2 without substrate.
Time (min)
MS 16. UPLC-MS chromatograms of a 24 h incubation of 7MDI-2 with IPP of masses 255.2 (red), 375.2 (orange), 455.1

































MS 19. UPLC-MS trace at 4.0 min of a 24 h incubation of 7Y-IDI-2 with IPP.
MS 20. UPLC-MS chromatograms of a 24 h incubation of 7MDI-2 with DMAPP of masses 255.2 (red), 375.2 (orange), 455.1




MS 21. UPLC-MS trace at 2.4 min of a 24 h incubation of 7MDI-2 with DMAPP. _




MS 23. UPLC-MS trace at 4.0 min of a 24 h incubation of 7MDI-2 with DMAPP.
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MS 24. UPLC-MS chromatograms of a 24 h incubation of Tt-IDI-2 with 13Cs-IPP of masses 255.2 (red), 375.2 (orange), 455.1
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MS 27. UPLC-MS trace at 3.9 min of a 24 h incubation of 7Y-IDI-2 with 13Cs-IPP.
Time (min)
MS 28. UPLC-MS chromatograms of a 27 d incubation of Tt-IDI-2 with IPP of masses 255.2 (red), 375.2 (orange), 455.1
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MS 30. UPLC-MS trace at 3.1 min of a 27 d incubation of 7Y-IDI-2 with IPP.





MS 31. UPLC-MS trace at 4.0 min of a 27 d incubation of 7Y-IDI-2 with IPP.
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1 0.01 181.00 1547.71 72.25 419.40
2 0.01 260.82 4081.07 30.50 2617.19
3 0.01 152.28 5346.21 82.98 2953.73
4 0.01 69.40 2218.46 118.82 1371.93
5 0.01 184.09 3274.86 149.53 1988.00
6 0.01 286.77 3430.84 677.16 3220.29
7 0.01 143.96 4186.53 319.46 3974.77
8 0.01 85.42 3634.26 215.22 3512.94
9 0.01 112.32 3423.18 255.48 3248.78
10 0.02 209.67 1439.15 83.17 380.38
11 0.02 285.91 4851.77 203.41 2667.39
12 0.02 346.06 3254.07 201.65 1915.41
13 0.02 491.74 3712.01 290.37 2159.65
14 0.02 279.26 3299.18 480.27 3052.97
15 0.02 226.58 3295.85 390.07 3043.26
16 0.02 296.78 3870.48 423.04 3709.97
17 0.02 190.53 3291.68 305.89 3097.22
18 0.04 334.28 2355.56 110.75 544.43
19 0.04 291.11 2694.37 172.62 1651.60
20 0.04 352.89 4297.60 220.74 2271.20
21 0.04 151.43 2984.30 83.88 1795.98
22 0.04 470.14 624.90 285.58 364.33
23 0.04 241.78 2865.93 464.60 2709.63
24 0.04 302.51 3018.82 432.99 2785.88
25 0.04 186.18 2629.40 359.32 2461.88
26 0.04 232.20 2267.59 340.14 2537.69
27 0.066 765.69 1501.76 826.36 569.69
28 0.066 747.87 2447.86 378.88 1510.23
29 0.066 500.05 3641.28 283.97 1889.54
30 0.066 784.06 3180.73 507.60 1818.77
31 0.066 475.12 2350.41 725.50 2127.84
32 0.066 420.64 3056.65 648.08 2807.96
33 0.11 555.07 1311.83 150.67 320.04
34 0.11 627.86 1672.01 299.04 863.88
35 0.11 744.57 2487.19 425.14 1330.35
36 0.11 968.77 1951.30 628.41 1130.26
37 0.11 505.43 2267.03 706.47 2086.47
38 0.11 504.10 1907.85 1555.74 1837.98
39 0.182 952.68 966.16 372.16 255.01
40 0.182 1092.50 1065.82 612.72 503.59
41 0.182 1008.03 2372.93 646.11 1251.50
42 0.182 1428.18 1634.77 870.03 955.76






























0.302 1185.23 2142.94 680.48 1119.82
0.302 1824.46 1424.19 1131.40 724.44
0.302 986.11 4677.19 2690.12 2590.54
0.302 694.08 1686.53 1023.85 1577.58
0.501 1140.56 710.15 584.78 298.16
0.501 1703.77 819.50 1016.88 395.54
0.501 1477.36 1391.35 857.02 695.77
0.501 726.58 1098.46 461.79 623.09
0.501 1780.94 942.50 1369.16 1501.95
0.501 1042.18 1073.65 1165.61 978.25
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1 0.01 660.73 2287.79 639.92 2008.02
2 0.01 1124.02 9908.21 354.69 2784.18
3 0.01 822.71 3653.69 592.18 2409.04
4 0.01 818.20 3641.97 570.58 2395.76
5 0.01 1149.52 3364.93 769.83 2122.72
6 0.01 908.60 3672.73 314.36 1240.18
7 0.01 623.18 2926.17 553.36 2618.61
8 0.01 487.13 2716.78 696.61 3984.56
9 0.01 55.44 1065.75 85.31 1438.21
10 0.01 420.46 2660.49 766.67 3468.60
11 0.01 383.96 2555.38 477.10 3109.01
12 0.01 400.09 2928.33 495.75 3615.57
13 0.02 1215.62 1733.29 1198.38 1569.30
14 0.02 2210.74 9755.05 668.27 2741.23
15 0.02 1476.93 3071.02 1073.42 2007.01
16 0.02 1481.33 2949.73 1044.88 1895.36
17 0.02 1897.30 3128.04 1281.12 1945.76
18 0.02 1737.67 3033.34 610.19 1013.98
19 0.02 1086.24 2614.90 858.09 2189.81
20 0.02 824.35 2316.88 1224.27 3357.57
21 0.02 858.57 2370.75 1239.77 3335.58
22 0.02 84.80 879.40 119.04 1179.23
23 0.02 795.04 2344.55 1050.34 3093.85
24 0.02 724.74 2399.56 900.60 2932.03
25 0.02 806.71 1983.14 938.77 2346.21
26 0.03 1487.75 1522.64 1494.89 1361.96
27 0.03 2773.76 9692.99 826.69 2710.94
28 0.03 1789.89 2800.58 1307.35 1775.10
29 0.03 2272.40 2884.69 1518.24 1765.28
30 0.03 2054.79 2795.79 729.29 885.82
31 0.03 1315.31 2289.43 1009.78 2177.65
32 0.03 1033.31 2026.60 1518.32 2950.71
33 0.03 1023.24 2178.95 1479.05 3193.29
34 0.03 78.06 827.16 107.68 1103.63
35 0.03 981.61 2276.94 1279.64 2976.35
36 0.03 960.15 2565.44 1194.37 3151.00
37 0.03 955.78 1910.41 1141.69 2250.58
38 0.04 1773.07 1343.39 1814.64 1173.25
39 0.04 3289.80 9111.12 984.70 2552.80
40 0.04 2042.53 2586.30 1466.10 1680.71
41 0.04 2591.09 2497.42 1725.48 1518.01
42 0.04 2369.86 2410.12 876.19 750.32







































0.04 1078.07 2341.37 1340.18 2912.08
0.04 1103.68 1812.78 1295.07 2108.08
0.08 2342.27 862.07 2323.39 725.88
0.08 4372.22 7463.45 1301.56 2064.74
0.08 2770.78 2034.25 1975.15 1263.59
0.08 3166.30 1803.51 1159.92 549.97
0.08 2001.16 1454.21 1489.08 1406.10
0.08 1553.43 1729.17 2252.58 2490.17
0.08 1507.77 1816.17 2036.77 2453.80
0.1 2544.86 749.40 2520.36 581.04
0.1 7396.18 4839.45 2024.70 1439.97
0.1 2889.73 1755.17 2092.62 1063.54
0.1 3023.94 1537.87 1079.89 470.85
0.1 2203.50 1300.85 1636.91 1288.67
0.1 1755.52 1646.32 2530.11 2364.67
0.1 1654.95 1721.11 2231.85 2311.75
0.1 1643.24 1634.43 2168.19 2074.83
0.1 1408.88 1777.33 1727.08 2145.02
0.1 1625.41 1412.43 1901.97 1639.57
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